<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Trials</journal-id><journal-id journal-id-type="iso-abbrev">Trials</journal-id><journal-title-group><journal-title>Trials</journal-title></journal-title-group><issn pub-type="epub">1745-6215</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29347947</article-id><article-id pub-id-type="pmc">5774158</article-id><article-id pub-id-type="publisher-id">2366</article-id><article-id pub-id-type="doi">10.1186/s13063-017-2366-9</article-id><article-categories><subj-group subj-group-type="heading"><subject>Study Protocol</subject></subj-group></article-categories><title-group><article-title>Efficacy of pre-operative quadriceps strength training on knee-extensor strength before and shortly following total knee arthroplasty: protocol for a randomized, dose-response trial (The QUADX-1 trial)</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Husted</surname><given-names>Rasmus Skov</given-names></name><address><email>rasmus.skov.husted@regionh.dk</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Troelsen</surname><given-names>Anders</given-names></name><address><email>anders.troelsen@regionh.dk</email></address><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Thorborg</surname><given-names>Kristian</given-names></name><address><email>kristian.thorborg@regionh.dk</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Rathleff</surname><given-names>Michael Skovdal</given-names></name><address><email>misr@hst.aau.dk</email></address><xref ref-type="aff" rid="Aff6">6</xref><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Husted</surname><given-names>Henrik</given-names></name><address><email>henrik.husted@regionh.dk</email></address><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Bandholm</surname><given-names>Thomas</given-names></name><address><email>thomas.quaade.bandholm@regionh.dk</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0646 8202</institution-id><institution-id institution-id-type="GRID">grid.411905.8</institution-id><institution>Physical Medicine and Rehabilitation Research - Copenhagen (PMR-C), </institution><institution>Copenhagen University Hospital Hvidovre, </institution></institution-wrap>Hvidovre, Denmark </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0646 8202</institution-id><institution-id institution-id-type="GRID">grid.411905.8</institution-id><institution>Department of Physical and Occupational Therapy, </institution><institution>Copenhagen University Hospital Hvidovre, </institution></institution-wrap>Hvidovre, Denmark </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0646 8202</institution-id><institution-id institution-id-type="GRID">grid.411905.8</institution-id><institution>Optimed, Clinical Research Centre, </institution><institution>Copenhagen University Hospital Hvidovre, </institution></institution-wrap>Hvidovre, Denmark </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0646 8202</institution-id><institution-id institution-id-type="GRID">grid.411905.8</institution-id><institution>Clinical Orthopedic Research Hvidovre (CORH), Department of Orthopedic Surgery, </institution><institution>Copenhagen University Hospital Hvidovre, </institution></institution-wrap>Hvidovre, Denmark </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0646 8202</institution-id><institution-id institution-id-type="GRID">grid.411905.8</institution-id><institution>Sports Orthopaedic Research Center – Copenhagen (SORC-C), Department of Orthopedic Surgery, </institution><institution>Copenhagen University Hospital Hvidovre, </institution></institution-wrap>Hvidovre, Denmark </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0742 471X</institution-id><institution-id institution-id-type="GRID">grid.5117.2</institution-id><institution>Research Unit for General Practice in Aalborg, Department of Clinical Medicine, </institution><institution>Aalborg University, </institution></institution-wrap>Aalborg, Denmark </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0646 7349</institution-id><institution-id institution-id-type="GRID">grid.27530.33</institution-id><institution>Department of Occupational Therapy and Physiotherapy, </institution><institution>Aalborg University Hospital, </institution></institution-wrap>Aalborg, Denmark </aff></contrib-group><pub-date pub-type="epub"><day>18</day><month>1</month><year>2018</year></pub-date><pub-date pub-type="pmc-release"><day>18</day><month>1</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>19</volume><elocation-id>47</elocation-id><history><date date-type="received"><day>2</day><month>10</month><year>2017</year></date><date date-type="accepted"><day>29</day><month>11</month><year>2017</year></date></history><permissions><copyright-statement>© The Author(s). 2018</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title><offsets xml_i="7040" xml_f="7050" txt_i="11" txt_f="21">Background</offsets></title><p id="Par1"><offsets xml_i="7071" xml_f="8165" txt_i="22" txt_f="1116">Patients with knee osteoarthritis (OA) report knee pain, limitation in physical activities and low quality of life. The two primary treatments for knee OA are non-surgical treatment (e.g., exercise) and surgery (total knee arthroplasty (TKA)); however, national guidelines recommend non-surgical treatment to be tried prior to surgical procedures. Patients with knee OA are characterized by decreased muscle strength, particularly in the knee-extensor muscles. Correspondingly, decreased knee-extensor strength is found to be associated with an increased risk of development, progression and severity of knee OA symptoms. Recent trials suggest a positive effect of pre-operative exercise on pre- and post-operative outcome; however, the most effective pre-operative knee-extensor strength exercise dosage is not known. The purpose of the present trial is to investigate the efficacy of three different exercise dosages of pre-operative, home-based, knee-extensor strength exercise on knee-extensor strength before and shortly after surgery in patients eligible for TKA due to end-stage knee OA.</offsets></p></sec><sec><title><offsets xml_i="8187" xml_f="8194" txt_i="1118" txt_f="1125">Methods</offsets></title><p id="Par2"><offsets xml_i="8215" xml_f="8938" txt_i="1126" txt_f="1849">In this randomized dose-response trial with a three-arm parallel design, 140 patients with end-stage knee OA (candidates for TKA) are randomized to one of three exercise dosages (two, four or six session/week) of knee-extensor strength exercise (three sets, 12 repetitions at 12 RM, per exercise session) for 12 weeks. The knee-extensor strength exercise is home-based (unsupervised) and performed with an elastic exercise band following an initial exercise instruction. Adherence is objectively quantified using a sensor attached to the exercise band. The primary outcome will be the change in knee-extensor strength. Following the 12-week exercise period, the need for TKA surgery is re-assessed by an orthopedic surgeon.</offsets></p></sec><sec><title><offsets xml_i="8960" xml_f="8970" txt_i="1851" txt_f="1861">Discussion</offsets></title><p id="Par3"><offsets xml_i="8991" xml_f="9531" txt_i="1862" txt_f="2402">Decreased knee-extensor strength is a major challenge in patients with knee OA. Exercise programs focusing on knee-extensor strength are found to be more effective in relieving knee OA pain and symptoms compared to more general exercise programs. However, the optimal exercise dosage for knee-extensor strength deficits in patients with knee OA is inconclusive. Knowledge on the dose-response relationship for knee-extensor strength exercise in patients with knee OA will help guide future non-surgical treatment in this patient population.</offsets></p></sec><sec><title><offsets xml_i="9553" xml_f="9571" txt_i="2404" txt_f="2422">Trial registration</offsets></title><p id="Par4"><offsets xml_i="9592" xml_f="9616" txt_i="2423" txt_f="2447">ClinicalTrials.gov, ID: </offsets><ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT02931058"><offsets xml_i="9707" xml_f="9718" txt_i="2447" txt_f="2458">NCT02931058</offsets></ext-link><offsets xml_i="9729" xml_f="9765" txt_i="2458" txt_f="2494">. Pre-registered on 10 October 2016.</offsets></p></sec><sec><title><offsets xml_i="9787" xml_f="9820" txt_i="2496" txt_f="2529">Electronic supplementary material</offsets></title><p><offsets xml_i="9831" xml_f="9966" txt_i="2530" txt_f="2665">The online version of this article (10.1186/s13063-017-2366-9) contains supplementary material, which is available to authorized users.</offsets></p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Knee osteoarthritis</kwd><kwd>Knee-extensor exercise</kwd><kwd>Exercise therapy</kwd><kwd>Strength training</kwd><kwd>Dose-response</kwd><kwd>Total knee arthroplasty</kwd></kwd-group><funding-group><award-group><funding-source><institution>The Capital Region´s strategic funds</institution></funding-source><award-id>128600000</award-id><principal-award-recipient><name><surname>Bandholm</surname><given-names>Thomas</given-names></name></principal-award-recipient></award-group><award-group><funding-source><institution>The Capital Region´s fund for cross-continuum research</institution></funding-source></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>© The Author(s) 2018</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title><offsets xml_i="10910" xml_f="10920" txt_i="2674" txt_f="2684">Background</offsets></title><p id="Par20"><offsets xml_i="10942" xml_f="11063" txt_i="2685" txt_f="2806">Patients diagnosed with knee osteoarthritis (OA) report pain, low quality of life and limitation in physical activities [</offsets><xref ref-type="bibr" rid="CR1"><offsets xml_i="11095" xml_f="11096" txt_i="2806" txt_f="2807">1</offsets></xref><offsets xml_i="11103" xml_f="11308" txt_i="2807" txt_f="3012">]. As a consequence, in Denmark, around 8000 patients with end-stage knee OA receive surgical treatment annually, in the form of total knee arthroplasty (TKA), to overcome their knee-related disabilities [</offsets><xref ref-type="bibr" rid="CR2"><offsets xml_i="11340" xml_f="11341" txt_i="3012" txt_f="3013">2</offsets></xref><offsets xml_i="11348" xml_f="11509" txt_i="3013" txt_f="3174">]. Currently, the two primary treatments for knee OA are non-surgical treatment (e.g., pain treatment, exercise and weight loss if indicated) and surgery (TKA) [</offsets><xref ref-type="bibr" rid="CR3"><offsets xml_i="11541" xml_f="11542" txt_i="3174" txt_f="3175">3</offsets></xref><offsets xml_i="11549" xml_f="11551" txt_i="3175" txt_f="3177">].</offsets></p><p id="Par21"><offsets xml_i="11569" xml_f="11688" txt_i="3178" txt_f="3297">There is preliminary evidence that pre-operative exercise may postpone total hip arthroplasty in patients with hip OA [</offsets><xref ref-type="bibr" rid="CR4"><offsets xml_i="11720" xml_f="11721" txt_i="3297" txt_f="3298">4</offsets></xref><offsets xml_i="11728" xml_f="12369" txt_i="3298" txt_f="3939">]. Likewise, pre-operative exercise in candidates for TKA will provide an optimized basis for deciding whether to commence TKA; e.g., patients experiencing pain relief and functional improvement following exercise might benefit from postponing their potential TKA and vice versa. The latest systematic review on the efficacy of pre-operative strength exercise to enhance post-operative recovery after TKA and THA concludes that pre-habilitation may slightly improve early post-operative pain and function among patients undergoing total joint replacement; but the effects are too small and short-lived to be considered clinically important [</offsets><xref ref-type="bibr" rid="CR5"><offsets xml_i="12401" xml_f="12402" txt_i="3939" txt_f="3940">5</offsets></xref><offsets xml_i="12409" xml_f="12529" txt_i="3940" txt_f="4060">]. However, this conclusion is based on trials with significant limitations, providing very low certainty in estimates [</offsets><xref ref-type="bibr" rid="CR5"><offsets xml_i="12561" xml_f="12562" txt_i="4060" txt_f="4061">5</offsets></xref><offsets xml_i="12569" xml_f="12571" txt_i="4061" txt_f="4063">].</offsets></p><p id="Par22"><offsets xml_i="12589" xml_f="12715" txt_i="4064" txt_f="4190">Recently, the first randomized controlled trial investigating the efficacy of TKA in patients eligible for TKA was conducted [</offsets><xref ref-type="bibr" rid="CR6"><offsets xml_i="12747" xml_f="12748" txt_i="4190" txt_f="4191">6</offsets></xref><offsets xml_i="12755" xml_f="13165" txt_i="4191" txt_f="4601">]. It showed an added effect (pain relief and functional improvement) of 30% by TKA and non-surgical treatment to that achieved by non-surgical treatment alone (30%). This highlights the importance of coordinating non-surgical and surgical care to select the right candidates for surgery, especially as patients undergoing TKA seem to experience more serious adverse events compared to non-surgical treatment [</offsets><xref ref-type="bibr" rid="CR6"><offsets xml_i="13197" xml_f="13198" txt_i="4601" txt_f="4602">6</offsets></xref><offsets xml_i="13205" xml_f="13646" txt_i="4602" txt_f="5043">]. These results suggest that non-surgical treatment should at least be tried out and considered before commencing surgical procedures. Optimally, patients awaiting TKA would conduct home-based, pre-operative exercise as the effect of exercise helps to establish the potential need for a future orthopedic operation. At the same time, it would be a potential solution of little cost and it enables the patients to self-manage their symptoms.</offsets></p><p id="Par23"><offsets xml_i="13664" xml_f="13871" txt_i="5044" txt_f="5251">Patients with knee OA are characterized by decreased knee-extensor strength and this decrease in knee-extensor strength is associated with limitation of activities of daily living, independent of knee pain [</offsets><xref ref-type="bibr" rid="CR7"><offsets xml_i="13903" xml_f="13904" txt_i="5251" txt_f="5252">7</offsets></xref><offsets xml_i="13911" xml_f="13913" txt_i="5252" txt_f="5254">, </offsets><xref ref-type="bibr" rid="CR8"><offsets xml_i="13945" xml_f="13946" txt_i="5254" txt_f="5255">8</offsets></xref><offsets xml_i="13953" xml_f="14143" txt_i="5255" txt_f="5445">]. Correspondingly, knee-extensor muscle weakness is found to be associated with increased risk of developing knee OA, progression of knee OA, symptoms of knee pain and decline in function [</offsets><xref ref-type="bibr" rid="CR9"><offsets xml_i="14175" xml_f="14176" txt_i="5445" txt_f="5446">9</offsets></xref><offsets xml_i="14183" xml_f="14185" txt_i="5446" txt_f="5448">, </offsets><xref ref-type="bibr" rid="CR10"><offsets xml_i="14218" xml_f="14220" txt_i="5448" txt_f="5450">10</offsets></xref><offsets xml_i="14227" xml_f="14433" txt_i="5450" txt_f="5656">]. Clinically, patients diagnosed with end-stage knee OA who are awaiting TKA to reduce pain and disability are reported to have 35% reduced knee-extensor strength compared to healthy, age-matched persons [</offsets><xref ref-type="bibr" rid="CR7"><offsets xml_i="14465" xml_f="14466" txt_i="5656" txt_f="5657">7</offsets></xref><offsets xml_i="14473" xml_f="14574" txt_i="5657" txt_f="5758">]. Shortly after TKA, patients lose an additional 80% of their pre-operative knee-extensor strength [</offsets><xref ref-type="bibr" rid="CR11"><offsets xml_i="14607" xml_f="14609" txt_i="5758" txt_f="5760">11</offsets></xref><offsets xml_i="14616" xml_f="14794" txt_i="5760" txt_f="5938">]. This massive loss in knee-extensor strength severely limits functional performance and may delay hospital discharge in the large number of patients undergoing TKA every year [</offsets><xref ref-type="bibr" rid="CR12"><offsets xml_i="14827" xml_f="14829" txt_i="5938" txt_f="5940">12</offsets></xref><offsets xml_i="14836" xml_f="15165" txt_i="5940" txt_f="6269">]. One of the latest systematic reviews on the efficacy of exercise to reduce pain and disability in patients with knee OA showed that isolated knee-extensor strength exercise was more effective in reducing pain and disability if not combined with other forms of exercises (e.g., other muscle groups or cardiovascular training) [</offsets><xref ref-type="bibr" rid="CR13"><offsets xml_i="15198" xml_f="15200" txt_i="6269" txt_f="6271">13</offsets></xref><offsets xml_i="15207" xml_f="15358" txt_i="6271" txt_f="6422">]. In line with this, the 2014 international guidelines for non-surgical management of knee OA include strength exercise of the knee-extensor muscles [</offsets><xref ref-type="bibr" rid="CR14"><offsets xml_i="15391" xml_f="15393" txt_i="6422" txt_f="6424">14</offsets></xref><offsets xml_i="15400" xml_f="15402" txt_i="6424" txt_f="6426">].</offsets></p><p id="Par24"><offsets xml_i="15420" xml_f="15646" txt_i="6427" txt_f="6653">Two recent randomized controlled trials have indicated that high-volume, pre-operative strength exercise may enhance pre- and post-operative knee-extensor strength as well as functional performance in patients undergoing TKA [</offsets><xref ref-type="bibr" rid="CR15"><offsets xml_i="15679" xml_f="15681" txt_i="6653" txt_f="6655">15</offsets></xref><offsets xml_i="15688" xml_f="15690" txt_i="6655" txt_f="6657">, </offsets><xref ref-type="bibr" rid="CR16"><offsets xml_i="15723" xml_f="15725" txt_i="6657" txt_f="6659">16</offsets></xref><offsets xml_i="15732" xml_f="15937" txt_i="6659" txt_f="6864">]. Hence, there are indications that the applied pre-operative exercise dose seems related to pre- and post-operative efficacy, making a dose-response trial of pre-operative exercise particularly relevant.</offsets></p><sec id="Sec2"><title><offsets xml_i="15963" xml_f="15970" txt_i="6865" txt_f="6872">Purpose</offsets></title><p id="Par25"><offsets xml_i="15992" xml_f="16314" txt_i="6873" txt_f="7195">The purpose of the present trial is to investigate the efficacy of three different exercise dosages (two, four and six exercise sessions per week) of pre-operative, home-based, knee-extensor strength exercise on knee-extensor strength before and shortly after surgery in patients eligible for TKA due to end-stage knee OA.</offsets></p></sec><sec id="Sec3"><title><offsets xml_i="16346" xml_f="16356" txt_i="7197" txt_f="7207">Hypothesis</offsets></title><p id="Par26"><offsets xml_i="16378" xml_f="16710" txt_i="7208" txt_f="7540">We hypothesize that a dosage of four knee-extensor strength exercise sessions per week will elicit the greatest strength increase pre-operatively compared to two or six sessions per week. The recommended minimum exercise dosage required for strength gains according the American College of Sports Medicine is two sessions per week [</offsets><xref ref-type="bibr" rid="CR17"><offsets xml_i="16743" xml_f="16745" txt_i="7540" txt_f="7542">17</offsets></xref><offsets xml_i="16752" xml_f="16974" txt_i="7542" txt_f="7764">]; therefore, two greater dosages are investigated and used as comparators. Four sessions per week is likely optimal and six sessions per week probably have no additional benefit, but could potentially increase knee pain [</offsets><xref ref-type="bibr" rid="CR18"><offsets xml_i="17007" xml_f="17009" txt_i="7764" txt_f="7766">18</offsets></xref><offsets xml_i="17016" xml_f="17018" txt_i="7766" txt_f="7768">, </offsets><xref ref-type="bibr" rid="CR19"><offsets xml_i="17051" xml_f="17053" txt_i="7768" txt_f="7770">19</offsets></xref><offsets xml_i="17060" xml_f="17062" txt_i="7770" txt_f="7772">].</offsets></p></sec></sec><sec id="Sec4"><title><offsets xml_i="17100" xml_f="17107" txt_i="7775" txt_f="7782">Methods</offsets></title><sec id="Sec5"><title><offsets xml_i="17137" xml_f="17172" txt_i="7783" txt_f="7818">Literature search and search matrix</offsets></title><p id="Par27"><offsets xml_i="17194" xml_f="17440" txt_i="7819" txt_f="8065">Before commencing the planning of this trial, a systematic literature search was conducted to locate trials investigating the same research question or planning to do so (protocols). The following search matrix (developed using a PICOT approach [</offsets><xref ref-type="bibr" rid="CR20"><offsets xml_i="17473" xml_f="17475" txt_i="8065" txt_f="8067">20</offsets></xref><offsets xml_i="17482" xml_f="17580" txt_i="8067" txt_f="8165">]) was used to search MedLine through pubmed.com on 18 November 2015 with weekly updated searches:</offsets></p><p id="Par28"><offsets xml_i="17598" xml_f="17637" txt_i="8166" txt_f="8205">(((((((((((“end stage osteoarthritis”) </offsets><italic><offsets xml_i="17645" xml_f="17647" txt_i="8205" txt_f="8207">or</offsets></italic><offsets xml_i="17656" xml_f="17683" txt_i="8207" txt_f="8234"> ((“Osteoarthritis”[Mesh]) </offsets><italic><offsets xml_i="17691" xml_f="17693" txt_i="8234" txt_f="8236">or</offsets></italic><offsets xml_i="17702" xml_f="17734" txt_i="8236" txt_f="8268"> “Osteoarthritis, Knee”[Mesh])) </offsets><italic><offsets xml_i="17742" xml_f="17744" txt_i="8268" txt_f="8270">or</offsets></italic><offsets xml_i="17753" xml_f="17773" txt_i="8270" txt_f="8290"> osteoarthritis)))) </offsets><italic><offsets xml_i="17781" xml_f="17783" txt_i="8290" txt_f="8292">or</offsets></italic><offsets xml_i="17792" xml_f="17833" txt_i="8292" txt_f="8333"> “knee osteoarthritis”[Title/Abstract])) </offsets><italic><offsets xml_i="17841" xml_f="17844" txt_i="8333" txt_f="8336">and</offsets></italic><offsets xml_i="17853" xml_f="17902" txt_i="8336" txt_f="8385"> (((((((((“resistance training”[Title/Abstract]) </offsets><italic><offsets xml_i="17910" xml_f="17912" txt_i="8385" txt_f="8387">or</offsets></italic><offsets xml_i="17921" xml_f="17951" txt_i="8387" txt_f="8417"> “Resistance Training”[Mesh]) </offsets><italic><offsets xml_i="17959" xml_f="17961" txt_i="8417" txt_f="8419">or</offsets></italic><offsets xml_i="17970" xml_f="18008" txt_i="8419" txt_f="8457"> “strength training”[Title/Abstract]) </offsets><italic><offsets xml_i="18016" xml_f="18018" txt_i="8457" txt_f="8459">or</offsets></italic><offsets xml_i="18027" xml_f="18059" txt_i="8459" txt_f="8491"> physiotherapy[Title/Abstract]) </offsets><italic><offsets xml_i="18067" xml_f="18069" txt_i="8491" txt_f="8493">or</offsets></italic><offsets xml_i="18078" xml_f="18115" txt_i="8493" txt_f="8530"> “Physical Therapy Specialty”[Mesh]) </offsets><italic><offsets xml_i="18123" xml_f="18125" txt_i="8530" txt_f="8532">or</offsets></italic><offsets xml_i="18134" xml_f="18172" txt_i="8532" txt_f="8570"> “Physical Therapy Modalities”[Mesh]) </offsets><italic><offsets xml_i="18180" xml_f="18182" txt_i="8570" txt_f="8572">or</offsets></italic><offsets xml_i="18191" xml_f="18234" txt_i="8572" txt_f="8615"> “knee extensor training”[Title/Abstract]) </offsets><italic><offsets xml_i="18242" xml_f="18244" txt_i="8615" txt_f="8617">or</offsets></italic><offsets xml_i="18253" xml_f="18293" txt_i="8617" txt_f="8657"> “quadriceps training”[Title/Abstract]) </offsets><italic><offsets xml_i="18301" xml_f="18303" txt_i="8657" txt_f="8659">or</offsets></italic><offsets xml_i="18312" xml_f="18355" txt_i="8659" txt_f="8702"> “pre-operative training”[Title/Abstract]) </offsets><italic><offsets xml_i="18363" xml_f="18365" txt_i="8702" txt_f="8704">or</offsets></italic><offsets xml_i="18374" xml_f="18413" txt_i="8704" txt_f="8743"> “physical function”[Title/Abstract])) </offsets><italic><offsets xml_i="18421" xml_f="18424" txt_i="8743" txt_f="8746">and</offsets></italic><offsets xml_i="18433" xml_f="18482" txt_i="8746" txt_f="8795"> ((((((“pre-operative strength”[Title/Abstract]) </offsets><italic><offsets xml_i="18490" xml_f="18492" txt_i="8795" txt_f="8797">or</offsets></italic><offsets xml_i="18501" xml_f="18544" txt_i="8797" txt_f="8840"> “knee extensor strength”[Title/Abstract]) </offsets><italic><offsets xml_i="18552" xml_f="18554" txt_i="8840" txt_f="8842">or</offsets></italic><offsets xml_i="18563" xml_f="18603" txt_i="8842" txt_f="8882"> “quadriceps strength”[Title/Abstract]) </offsets><italic><offsets xml_i="18611" xml_f="18613" txt_i="8882" txt_f="8884">or</offsets></italic><offsets xml_i="18622" xml_f="18637" txt_i="8884" txt_f="8899"> “Pain”[Mesh]) </offsets><italic><offsets xml_i="18645" xml_f="18647" txt_i="8899" txt_f="8901">or</offsets></italic><offsets xml_i="18656" xml_f="18679" txt_i="8901" txt_f="8924"> pain[Title/Abstract]) </offsets><italic><offsets xml_i="18687" xml_f="18689" txt_i="8924" txt_f="8926">or</offsets></italic><offsets xml_i="18698" xml_f="18730" txt_i="8926" txt_f="8958"> “Musculoskeletal Pain”[Mesh])) </offsets><italic><offsets xml_i="18738" xml_f="18741" txt_i="8958" txt_f="8961">and</offsets></italic><offsets xml_i="18750" xml_f="18801" txt_i="8961" txt_f="9012"> (((((((“post-operative strength”[Title/Abstract]) </offsets><italic><offsets xml_i="18809" xml_f="18811" txt_i="9012" txt_f="9014">or</offsets></italic><offsets xml_i="18820" xml_f="18878" txt_i="9014" txt_f="9072"> “post-operative knee extensor strength”[Title/Abstract]) </offsets><italic><offsets xml_i="18886" xml_f="18888" txt_i="9072" txt_f="9074">or</offsets></italic><offsets xml_i="18897" xml_f="18940" txt_i="9074" txt_f="9117"> “knee extensor strength”[Title/Abstract]) </offsets><italic><offsets xml_i="18948" xml_f="18950" txt_i="9117" txt_f="9119">or</offsets></italic><offsets xml_i="18959" xml_f="18999" txt_i="9119" txt_f="9159"> “quadriceps strength”[Title/Abstract]) </offsets><italic><offsets xml_i="19007" xml_f="19009" txt_i="9159" txt_f="9161">or</offsets></italic><offsets xml_i="19018" xml_f="19033" txt_i="9161" txt_f="9176"> “Pain”[Mesh]) </offsets><italic><offsets xml_i="19041" xml_f="19043" txt_i="9176" txt_f="9178">or</offsets></italic><offsets xml_i="19052" xml_f="19075" txt_i="9178" txt_f="9201"> pain[Title/Abstract]) </offsets><italic><offsets xml_i="19083" xml_f="19085" txt_i="9201" txt_f="9203">or</offsets></italic><offsets xml_i="19094" xml_f="19125" txt_i="9203" txt_f="9234"> “Musculoskeletal Pain”[Mesh]) </offsets><italic><offsets xml_i="19133" xml_f="19136" txt_i="9234" txt_f="9237">and</offsets></italic><offsets xml_i="19145" xml_f="19184" txt_i="9237" txt_f="9276"> (((((((meta-analysis[Title/Abstract]) </offsets><italic><offsets xml_i="19192" xml_f="19194" txt_i="9276" txt_f="9278">or</offsets></italic><offsets xml_i="19203" xml_f="19239" txt_i="9278" txt_f="9314"> “Meta-Analysis”[Publication Type]) </offsets><italic><offsets xml_i="19247" xml_f="19249" txt_i="9314" txt_f="9316">or</offsets></italic><offsets xml_i="19258" xml_f="19296" txt_i="9316" txt_f="9354"> “systematic review”[Title/Abstract]) </offsets><italic><offsets xml_i="19304" xml_f="19306" txt_i="9354" txt_f="9356">or</offsets></italic><offsets xml_i="19315" xml_f="19344" txt_i="9356" txt_f="9385"> “Review”[Publication Type]) </offsets><italic><offsets xml_i="19352" xml_f="19354" txt_i="9385" txt_f="9387">or</offsets></italic><offsets xml_i="19363" xml_f="19411" txt_i="9387" txt_f="9435"> “randomized controlled trial”[Title/Abstract]) </offsets><italic><offsets xml_i="19419" xml_f="19421" txt_i="9435" txt_f="9437">or</offsets></italic><offsets xml_i="19430" xml_f="19480" txt_i="9437" txt_f="9487"> “Randomized Controlled Trial”[Publication Type]) </offsets><italic><offsets xml_i="19488" xml_f="19490" txt_i="9487" txt_f="9489">or</offsets></italic><offsets xml_i="19499" xml_f="19538" txt_i="9489" txt_f="9528"> “prospective cohort”[Title/Abstract]).</offsets></p><p id="Par29"><offsets xml_i="19556" xml_f="19900" txt_i="9529" txt_f="9873">Systematic reviews and meta-analyses were found but none specifically addressed the pre-operative effect on muscle strength of a single knee-extensor strength exercise in patients with knee OA. No Cochrane reviews were found. An updated search was performed on 1 May 2017 providing new academic literature relevant for the scope of this trial [</offsets><xref ref-type="bibr" rid="CR21"><offsets xml_i="19933" xml_f="19935" txt_i="9873" txt_f="9875">21</offsets></xref><offsets xml_i="19942" xml_f="19944" txt_i="9875" txt_f="9877">, </offsets><xref ref-type="bibr" rid="CR22"><offsets xml_i="19977" xml_f="19979" txt_i="9877" txt_f="9879">22</offsets></xref><offsets xml_i="19986" xml_f="19988" txt_i="9879" txt_f="9881">].</offsets></p></sec><sec id="Sec6"><title><offsets xml_i="20020" xml_f="20032" txt_i="9883" txt_f="9895">Trial design</offsets></title><p id="Par30"><offsets xml_i="20054" xml_f="20077" txt_i="9896" txt_f="9919">The trial is named the </offsets><italic><offsets xml_i="20085" xml_f="20098" txt_i="9919" txt_f="9932">QUADX-1 trial</offsets></italic><offsets xml_i="20107" xml_f="20637" txt_i="9932" txt_f="10462">. It uses a three-arm, parallel-group, randomized trial design with three intervention groups (exercise dosages) and no control group. No control group is included as the primary purpose of the trial is to investigate the dose-response relationship of the investigated knee-extensor strength exercise dosages. Based on the sample size estimation outlined below, 140 patients will be randomized (1:1:1) to one of three exercise dosages for 12 weeks. Outcomes will be assessed blinded at baseline before the start of the exercise (t</offsets><sub><offsets xml_i="20642" xml_f="20643" txt_i="10462" txt_f="10463">0</offsets></sub><offsets xml_i="20649" xml_f="20720" txt_i="10463" txt_f="10534">), after the exercise intervention, which is before possible surgery (t</offsets><sub><offsets xml_i="20725" xml_f="20726" txt_i="10534" txt_f="10535">1</offsets></sub><offsets xml_i="20732" xml_f="20815" txt_i="10535" txt_f="10618">, primary endpoint), at hospital discharge 1–8 days after surgery (if performed) (t</offsets><sub><offsets xml_i="20820" xml_f="20821" txt_i="10618" txt_f="10619">2</offsets></sub><offsets xml_i="20827" xml_f="20886" txt_i="10619" txt_f="10678">) and, finally, at 3 months after surgery (if performed) (t</offsets><sub><offsets xml_i="20891" xml_f="20892" txt_i="10678" txt_f="10679">3</offsets></sub><offsets xml_i="20898" xml_f="20951" txt_i="10679" txt_f="10732">). A flow chart of the trial is provided below (Fig. </offsets><xref rid="Fig1" ref-type="fig"><offsets xml_i="20983" xml_f="20984" txt_i="10732" txt_f="10733">1</offsets></xref><offsets xml_i="20991" xml_f="20993" txt_i="10733" txt_f="10735">).</offsets><fig id="Fig1"><label><offsets xml_i="21015" xml_f="21021" txt_i="10735" txt_f="10741">Fig. 1</offsets></label><caption><p><offsets xml_i="21041" xml_f="21105" txt_i="10741" txt_f="10805">Flow chart of enrollment, randomization, treatment and follow-up</offsets></p></caption><graphic xlink:href="13063_2017_2366_Fig1_HTML" id="MO1"></graphic></fig></p><p id="Par31"><offsets xml_i="21210" xml_f="21276" txt_i="10807" txt_f="10873">This clinical trial protocol is based on the PREPARE trial guide [</offsets><xref ref-type="bibr" rid="CR23"><offsets xml_i="21309" xml_f="21311" txt_i="10873" txt_f="10875">23</offsets></xref><offsets xml_i="21318" xml_f="21351" txt_i="10875" txt_f="10908">] and the SPIRIT Checklist (Fig. </offsets><xref rid="Fig2" ref-type="fig"><offsets xml_i="21383" xml_f="21384" txt_i="10908" txt_f="10909">2</offsets></xref><offsets xml_i="21391" xml_f="21409" txt_i="10909" txt_f="10927">, Additional file </offsets><xref rid="MOESM1" ref-type="media"><offsets xml_i="21445" xml_f="21446" txt_i="10927" txt_f="10928">1</offsets></xref><offsets xml_i="21453" xml_f="21456" txt_i="10928" txt_f="10931">) [</offsets><xref ref-type="bibr" rid="CR24"><offsets xml_i="21489" xml_f="21491" txt_i="10931" txt_f="10933">24</offsets></xref><offsets xml_i="21498" xml_f="21656" txt_i="10933" txt_f="11091">]. The trial report will adhere to the Consolidated Standards of Reporting Trials (CONSORT) Checklist using the extension for non-pharmacological treatments [</offsets><xref ref-type="bibr" rid="CR25"><offsets xml_i="21689" xml_f="21691" txt_i="11091" txt_f="11093">25</offsets></xref><offsets xml_i="21698" xml_f="21781" txt_i="11093" txt_f="11176">]. The TIDieR Checklist will be used for intervention description (Additional file </offsets><xref rid="MOESM2" ref-type="media"><offsets xml_i="21817" xml_f="21818" txt_i="11176" txt_f="11177">2</offsets></xref><offsets xml_i="21825" xml_f="21828" txt_i="11177" txt_f="11180">) [</offsets><xref ref-type="bibr" rid="CR26"><offsets xml_i="21861" xml_f="21863" txt_i="11180" txt_f="11182">26</offsets></xref><offsets xml_i="21870" xml_f="21961" txt_i="11182" txt_f="11273">]. The trial was pre-registered at ClinicalTrials.gov on 10 October 2016 (ID: NCT02931058, </offsets><ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT02931058"><offsets xml_i="22052" xml_f="22099" txt_i="11273" txt_f="11320">https://clinicaltrials.gov/ct2/show/NCT02931058</offsets></ext-link><offsets xml_i="22110" xml_f="22527" txt_i="11320" txt_f="11737">) and approvals with the Ethics Committee of the Capital Region Denmark (ID: H-16025136) and the Danish Data Protection Agency (J. nr.: 2012-58-0004. Lokale RegH j. nr.: AHH-2016-072, med I-Suite nr.: 04980) were obtained before the first patient was enrolled. The trial will be conducted at Copenhagen University Hospital Hvidovre and in the collaborating municipalities of Copenhagen, Hvidovre and Brøndby, Denmark.</offsets><fig id="Fig2"><label><offsets xml_i="22549" xml_f="22555" txt_i="11737" txt_f="11743">Fig. 2</offsets></label><caption><p><offsets xml_i="22575" xml_f="22714" txt_i="11743" txt_f="11882">Schedule for enrollment, intervention and outcome assessments (Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT))</offsets></p></caption><graphic xlink:href="13063_2017_2366_Fig2_HTML" id="MO2"></graphic></fig></p></sec><sec id="Sec7"><title><offsets xml_i="22833" xml_f="22844" txt_i="11885" txt_f="11896">Recruitment</offsets></title><p id="Par32"><offsets xml_i="22866" xml_f="25079" txt_i="11897" txt_f="14110">All patients will be included by consecutive sampling from the orthopedic outpatient clinic at Copenhagen University Hospital, Hvidovre. At the orthopedic outpatient clinic, possible patients for TKA surgery due to end-stage knee OA are introduced to the trial and offered to participate by the orthopedic surgeon if they fit the initial eligibility criteria (please see below). On the same day, eligible patients interested in participating in the trial are then referred to a research assistant who provides thorough oral and written information about the trial. Eligible patients are informed that participation in the project includes 12 weeks of home-based, knee-extensor strength exercise with the purpose of improving knee-extensor strength, relieving knee pain and improving functional performance. Further, they are informed that after the exercise period, they will be re-assessed at the orthopedic outpatient clinic with regards to undergo surgery or not. To prevent performance bias, eligible patients are blinded to the exercise dosage randomization as well as the trial hypothesis. Information about the trial is provided in a calm setting dedicated to the trial. Should the patients wish for a companion to be present during the information meeting a new information appointment is scheduled. Along with the information, a second more thorough screening of inclusion and exclusion criteria is commenced. The patients are given a minimum of 24 h to decide whether they would like to participate in the trial or not. If the patients decide to participate, a baseline assessment is scheduled. Written informed consent is obtained at the baseline assessment. Once written informed consent and baseline assessment is completed, the patient is fully included in the trial. Outcome assessments will be performed blinded by the primary investigator and a research assistant dedicated to the trial, who are both trained according to the trial outcome-assessment protocol to ensure standardized assessments throughout the trial. To further refine and ensure standardization of the trial outcome-assessment protocol we piloted the outcome-assessment procedures in seven patients prior to initiating the trial.</offsets></p></sec><sec id="Sec8"><title><offsets xml_i="25111" xml_f="25128" txt_i="14112" txt_f="14129">Eligible criteria</offsets></title><sec id="Sec9"><title><offsets xml_i="25158" xml_f="25176" txt_i="14130" txt_f="14148">Inclusion criteria</offsets></title><p id="Par33"><offsets xml_i="25198" xml_f="25199" txt_i="14149" txt_f="14150">
</offsets><list list-type="bullet"><list-item><p id="Par34"><offsets xml_i="25249" xml_f="25340" txt_i="14150" txt_f="14241">Patient is a possible candidate for a primary TKA due to knee OA, based on the below terms:</offsets><list list-type="bullet"><list-item><p id="Par35"><offsets xml_i="25390" xml_f="25445" txt_i="14241" txt_f="14296">◦ Knee pain ≥ 3 (Numeric Rating Scale) in the last week</offsets></p></list-item><list-item><p id="Par36"><offsets xml_i="25486" xml_f="25530" txt_i="14297" txt_f="14341">◦ Kellgren-Lawrence classification grade ≥ 2</offsets></p></list-item></list></p></list-item><list-item><p id="Par37"><offsets xml_i="25594" xml_f="25661" txt_i="14343" txt_f="14410">Patient is eligible for home-based, knee-extensor strength exercise</offsets></p></list-item><list-item><p id="Par38"><offsets xml_i="25702" xml_f="25727" txt_i="14411" txt_f="14436">Patient is age ≥ 45 years</offsets></p></list-item><list-item><p id="Par39"><offsets xml_i="25768" xml_f="25877" txt_i="14437" txt_f="14546">Patient is resident in one of the three municipalities (København, Hvidovre or Brøndby) involved in the trial</offsets></p></list-item><list-item><p id="Par40"><offsets xml_i="25918" xml_f="25964" txt_i="14547" txt_f="14593">Patient is able to speak and understand Danish</offsets></p></list-item></list><offsets xml_i="25987" xml_f="25988" txt_i="14594" txt_f="14595">
</offsets></p></sec><sec id="Sec10"><title><offsets xml_i="26021" xml_f="26039" txt_i="14597" txt_f="14615">Exclusion criteria</offsets></title><p id="Par41"><offsets xml_i="26061" xml_f="26062" txt_i="14616" txt_f="14617">
</offsets><list list-type="bullet"><list-item><p id="Par42"><offsets xml_i="26112" xml_f="26156" txt_i="14617" txt_f="14661">Exercise is contra-indicated for the patient</offsets></p></list-item><list-item><p id="Par43"><offsets xml_i="26197" xml_f="26232" txt_i="14662" txt_f="14697">Patient has a neurological disorder</offsets></p></list-item><list-item><p id="Par44"><offsets xml_i="26273" xml_f="26401" txt_i="14698" txt_f="14826">Patient has a diagnosed systemic disease (American Society of Anesthesiologists’ physical status classification score (ASA) ≥ 4)</offsets></p></list-item><list-item><p id="Par45"><offsets xml_i="26442" xml_f="26471" txt_i="14827" txt_f="14856">Patient with terminal illness</offsets></p></list-item><list-item><p id="Par46"><offsets xml_i="26512" xml_f="26584" txt_i="14857" txt_f="14929">Patient has severe bone deformity demanding use of non-standard implants</offsets></p></list-item><list-item><p id="Par47"><offsets xml_i="26625" xml_f="26729" txt_i="14930" txt_f="15028">Weekly alcohol consumption above national recommendations (&gt;7 units for women, &gt; 14 units for men)</offsets></p></list-item></list><offsets xml_i="26752" xml_f="26753" txt_i="15029" txt_f="15030">
</offsets></p></sec><sec id="Sec11"><title><offsets xml_i="26786" xml_f="26805" txt_i="15032" txt_f="15051">Protocol amendments</offsets></title><p id="Par48"><offsets xml_i="26827" xml_f="26828" txt_i="15052" txt_f="15053">
</offsets><list list-type="bullet"><list-item><p id="Par49"><offsets xml_i="26878" xml_f="26914" txt_i="15053" txt_f="15089">8 February 2017: Inclusion criteria </offsets><italic><offsets xml_i="26922" xml_f="26925" txt_i="15089" txt_f="15092">age</offsets></italic><offsets xml_i="26934" xml_f="26948" txt_i="15092" txt_f="15106"> changed from </offsets><italic><offsets xml_i="26956" xml_f="26966" txt_i="15106" txt_f="15116">≥ 50 years</offsets></italic><offsets xml_i="26975" xml_f="26979" txt_i="15116" txt_f="15120"> to </offsets><italic><offsets xml_i="26987" xml_f="26997" txt_i="15120" txt_f="15130">≥ 45 years</offsets></italic><offsets xml_i="27006" xml_f="27324" txt_i="15130" txt_f="15448">. The rationale for this modification is that patients aged 45–49 years with knee OA who are possible candidates for TKA are likely to benefit from participation. Recent comparable trials of pre-operative exercise on the same population had age-related inclusion criteria including the age-span of 45–49 years of age [</offsets><xref ref-type="bibr" rid="CR27"><offsets xml_i="27357" xml_f="27359" txt_i="15448" txt_f="15450">27</offsets></xref><offsets xml_i="27366" xml_f="27368" txt_i="15450" txt_f="15452">, </offsets><xref ref-type="bibr" rid="CR28"><offsets xml_i="27401" xml_f="27403" txt_i="15452" txt_f="15454">28</offsets></xref><offsets xml_i="27410" xml_f="27411" txt_i="15454" txt_f="15455">]</offsets></p></list-item><list-item><p id="Par50"><offsets xml_i="27452" xml_f="27488" txt_i="15456" txt_f="15492">8 February 2017: Exclusion criteria </offsets><italic><offsets xml_i="27496" xml_f="27505" txt_i="15492" txt_f="15501">ASA score</offsets></italic><offsets xml_i="27514" xml_f="27528" txt_i="15501" txt_f="15515"> changed from </offsets><italic><offsets xml_i="27536" xml_f="27539" txt_i="15515" txt_f="15518">≥ 3</offsets></italic><offsets xml_i="27548" xml_f="27552" txt_i="15518" txt_f="15522"> to </offsets><italic><offsets xml_i="27560" xml_f="27563" txt_i="15522" txt_f="15525">≥ 4</offsets></italic><offsets xml_i="27572" xml_f="27826" txt_i="15525" txt_f="15779">. The rationale for changing the exclusion criteria relating to the ASA score is that patients with knee OA and an ASA score of 3 who are possible candidates for TKA are likely to benefit from participating in the trial. An ASA score of 3 is defined as “</offsets><italic><offsets xml_i="27834" xml_f="27872" txt_i="15779" txt_f="15817">A patient with severe systemic disease</offsets></italic><offsets xml_i="27881" xml_f="27923" txt_i="15817" txt_f="15859">,” while an ASA score of 4 is defined as “</offsets><italic><offsets xml_i="27931" xml_f="28003" txt_i="15859" txt_f="15931">A patient with severe systemic disease that is a constant threat to life</offsets></italic><offsets xml_i="28012" xml_f="28015" txt_i="15931" txt_f="15934">” [</offsets><xref ref-type="bibr" rid="CR29"><offsets xml_i="28048" xml_f="28050" txt_i="15934" txt_f="15936">29</offsets></xref><offsets xml_i="28057" xml_f="28314" txt_i="15936" txt_f="16193">]. One definition-difference between ASA score 3 and 4 is the functional capacity, where a patient with an ASA score of 3 is able to complete a flight of stairs or walk 200 m on level ground, whereas a patient with an ASA score of 4 is not able to do this [</offsets><xref ref-type="bibr" rid="CR29"><offsets xml_i="28347" xml_f="28349" txt_i="16193" txt_f="16195">29</offsets></xref><offsets xml_i="28356" xml_f="28498" txt_i="16195" txt_f="16337">]. Thus, patients with knee OA and an ASA score of 3 who are possible candidates for TKA are able to participate in the present exercise trial</offsets></p></list-item><list-item><p id="Par51"><offsets xml_i="28539" xml_f="28573" txt_i="16338" txt_f="16372">30 March 2017: Inclusion criteria </offsets><italic><offsets xml_i="28581" xml_f="28636" txt_i="16372" txt_f="16427">knee pain (Numeric Rating Scale (NRS)) in the last week</offsets></italic><offsets xml_i="28645" xml_f="28659" txt_i="16427" txt_f="16441"> changed from </offsets><italic><offsets xml_i="28667" xml_f="28673" txt_i="16441" txt_f="16444">&gt; 3</offsets></italic><offsets xml_i="28682" xml_f="28686" txt_i="16444" txt_f="16448"> to </offsets><italic><offsets xml_i="28694" xml_f="28697" txt_i="16448" txt_f="16451">≥ 3</offsets></italic><offsets xml_i="28706" xml_f="29082" txt_i="16451" txt_f="16824">. The rational for changing the NRS from &gt; 3 to ≥ 3 is that some patients who are considered candidates for total knee replacement might not have pain scores higher than 3. Thus, they might end up being excluded from the trial even though they are clinically considered candidates for total knee replacement. Hence, this change was made to reflect current clinical practice</offsets></p></list-item><list-item><p id="Par52"><offsets xml_i="29123" xml_f="29157" txt_i="16825" txt_f="16859">30 March 2017: Inclusion criteria </offsets><italic><offsets xml_i="29165" xml_f="29182" txt_i="16859" txt_f="16876">Oxford Knee Score</offsets></italic><offsets xml_i="29191" xml_f="29597" txt_i="16876" txt_f="17282"> (OKS) was removed as an inclusion criterion but still kept as a descriptive and effect outcome. The rationale for this modification (removing OKS as an inclusion criteria) is that OKS is not used in daily clinic practice as a means of assessing whether a patient is a candidate for TKA or not. Thus, keeping the OKS as an inclusion criterion in the QUADX-1 trial will not reflect current clinical practice</offsets></p></list-item><list-item><p id="Par53"><offsets xml_i="29638" xml_f="29776" txt_i="17283" txt_f="17421">All the above protocol amendments are approved by the Ethics Committee of the Capitol Region Denmark (ID: H-16025136; 55528, 55529, 57312)</offsets></p></list-item></list><offsets xml_i="29799" xml_f="29800" txt_i="17422" txt_f="17423">
</offsets></p></sec></sec><sec id="Sec12"><title><offsets xml_i="29839" xml_f="29851" txt_i="17426" txt_f="17438">Intervention</offsets></title><p id="Par54"><offsets xml_i="29873" xml_f="30590" txt_i="17439" txt_f="18156">Once the baseline assessment is completed, the patients are referred to their local municipality rehabilitation setting for knee-extensor strength exercise instruction. The initial exercise instruction takes place there, where the patients are received by a trial-dedicated physiotherapist who is specialized in instructing and training patients with knee OA. Once the instruction is completed and the patients are comfortable with the exercise, an exercise session is completed under supervision from the physiotherapist. The patients are handed personal elastic exercise bands for exercise at home and a study-specific brochure where instruction notes to the exercise are illustrated and described (Additional file </offsets><xref rid="MOESM3" ref-type="media"><offsets xml_i="30626" xml_f="30627" txt_i="18156" txt_f="18157">3</offsets></xref><offsets xml_i="30634" xml_f="30846" txt_i="18157" txt_f="18369">). All the physiotherapists dedicated to the trial were trained by the primary investigator prior to the start of the trial to ensure standardized exercise instruction and information across the physiotherapists.</offsets></p><p id="Par55"><offsets xml_i="30864" xml_f="31385" txt_i="18370" txt_f="18891">The intervention period is 12 weeks. After 4 and 8 weeks of exercise, the patients have an exercise quality check-up (booster visit) with the physiotherapist in the municipality setting. The exercise quality check-up includes exercise technique re-assessment (fractional and temporal distribution of the contraction modes, range of motion and positioning), ensuring optimal length or type of elastic exercise band (resistance corresponding to 12 repetitions-maximum (RM)) and exercise-related questions from the patients.</offsets></p><p id="Par56"><offsets xml_i="31403" xml_f="31533" txt_i="18892" txt_f="19022">Three exercise dosages are investigated; two, four and six sessions per week for 12 weeks (group 2, 4 and 6, respectively) (Table </offsets><xref rid="Tab1" ref-type="table"><offsets xml_i="31567" xml_f="31568" txt_i="19022" txt_f="19023">1</offsets></xref><offsets xml_i="31575" xml_f="32111" txt_i="19023" txt_f="19559">). Each exercise session comprises a single-strength training exercise, knee-extension, which is performed in three sets with 12 repetitions at a load corresponding to 12 RM in each set. There is no control group. The patients are randomly allocated to one of the three exercise dosages. The patients are instructed to perform only one exercise session per day. That is, they are not allowed to combine several exercise sessions on the same day. For example, patients randomized to group 6 are instructed to exercise 6 days of the week.</offsets><table-wrap id="Tab1"><label><offsets xml_i="32140" xml_f="32147" txt_i="19559" txt_f="19566">Table 1</offsets></label><caption><p><offsets xml_i="32167" xml_f="32236" txt_i="19566" txt_f="19635">Exercise sessions per week according to exercise dosage randomization</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><th><offsets xml_i="32302" xml_f="32315" txt_i="19636" txt_f="19649">Dosage groups</offsets></th><th colspan="6"><offsets xml_i="32336" xml_f="32349" txt_i="19649" txt_f="19662">Sessions/week</offsets></th></tr></thead><tbody><tr><td><offsets xml_i="32382" xml_f="32405" txt_i="19662" txt_f="19685">Gp. 2 – 2 sessions/week</offsets></td><td colspan="3"><offsets xml_i="32426" xml_f="32433" txt_i="19686" txt_f="19693">3*12 RM</offsets></td><td colspan="3"><offsets xml_i="32454" xml_f="32461" txt_i="19694" txt_f="19701">3*12 RM</offsets></td></tr><tr><td><offsets xml_i="32479" xml_f="32502" txt_i="19702" txt_f="19725">Gp. 4 – 4 sessions/week</offsets></td><td><offsets xml_i="32511" xml_f="32518" txt_i="19726" txt_f="19733">3*12 RM</offsets></td><td colspan="2"><offsets xml_i="32539" xml_f="32546" txt_i="19734" txt_f="19741">3*12 RM</offsets></td><td><offsets xml_i="32555" xml_f="32562" txt_i="19742" txt_f="19749">3*12 RM</offsets></td><td colspan="2"><offsets xml_i="32583" xml_f="32590" txt_i="19750" txt_f="19757">3*12 RM</offsets></td></tr><tr><td><offsets xml_i="32608" xml_f="32631" txt_i="19758" txt_f="19781">Gp. 6 – 6 sessions/week</offsets></td><td><offsets xml_i="32640" xml_f="32647" txt_i="19782" txt_f="19789">3*12 RM</offsets></td><td><offsets xml_i="32656" xml_f="32663" txt_i="19790" txt_f="19797">3*12 RM</offsets></td><td><offsets xml_i="32672" xml_f="32679" txt_i="19798" txt_f="19805">3*12 RM</offsets></td><td><offsets xml_i="32688" xml_f="32695" txt_i="19806" txt_f="19813">3*12 RM</offsets></td><td><offsets xml_i="32704" xml_f="32711" txt_i="19814" txt_f="19821">3*12 RM</offsets></td><td><offsets xml_i="32720" xml_f="32727" txt_i="19822" txt_f="19829">3*12 RM</offsets></td></tr></tbody></table><table-wrap-foot><p><offsets xml_i="32773" xml_f="32816" txt_i="19830" txt_f="19873">Knee-extensor exercise dosages investigated</offsets></p></table-wrap-foot></table-wrap></p><p id="Par57"><offsets xml_i="32869" xml_f="33767" txt_i="19875" txt_f="20773">The intervention is personalized to the extent where each patient is exercising with an individual absolute resistance in the elastic exercise band corresponding to a relative load of 12 RM. Contractions should be continued until volitional muscular failure. That is, until the knee-extensor muscles are maximally fatigued and the patient is not able to perform further repetitions. If volitional muscular failure occurs before 12 RM, the resistance of the elastic band is adjusted so that the pre-determined number of repetitions can be completed. Whenever a given resistance in the elastic exercise band becomes too low (i.e., more than 12 repetitions per set can be performed), the patients are instructed to adjust the resistance in the elastic exercise band (increase the distance between the two endpoints of the elastic exercise band, i.e., moving the chair further away from the door (Fig. </offsets><xref rid="Fig3" ref-type="fig"><offsets xml_i="33799" xml_f="33800" txt_i="20773" txt_f="20774">3</offsets></xref><offsets xml_i="33807" xml_f="33935" txt_i="20774" txt_f="20902">)) to achieve a new resistance corresponding to a relative load of 12 RM. The home-based, knee-extensor strength exercise (Fig. </offsets><xref rid="Fig3" ref-type="fig"><offsets xml_i="33967" xml_f="33968" txt_i="20902" txt_f="20903">3</offsets></xref><offsets xml_i="33975" xml_f="33985" txt_i="20903" txt_f="20913"> and Fig. </offsets><xref rid="Fig9" ref-type="fig"><offsets xml_i="34017" xml_f="34018" txt_i="20913" txt_f="20914">9</offsets></xref><offsets xml_i="34025" xml_f="34055" txt_i="20914" txt_f="20944">, Supplementary online video [</offsets><xref ref-type="bibr" rid="CR30"><offsets xml_i="34088" xml_f="34090" txt_i="20944" txt_f="20946">30</offsets></xref><offsets xml_i="34097" xml_f="34136" txt_i="20946" txt_f="20985">]) is described in detail below (Table </offsets><xref rid="Tab2" ref-type="table"><offsets xml_i="34170" xml_f="34171" txt_i="20985" txt_f="20986">2</offsets></xref><offsets xml_i="34178" xml_f="34255" txt_i="20986" txt_f="21063">) according to the mechano-biological descriptors from Toigo and Boutellier [</offsets><xref ref-type="bibr" rid="CR31"><offsets xml_i="34288" xml_f="34290" txt_i="21063" txt_f="21065">31</offsets></xref><offsets xml_i="34297" xml_f="34299" txt_i="21065" txt_f="21067">].</offsets><fig id="Fig3"><label><offsets xml_i="34321" xml_f="34327" txt_i="21067" txt_f="21073">Fig. 3</offsets></label><caption><p><offsets xml_i="34347" xml_f="34394" txt_i="21073" txt_f="21120">The home-based, knee-extensor strength exercise</offsets></p></caption><graphic xlink:href="13063_2017_2366_Fig3_HTML" id="MO3"></graphic></fig><table-wrap id="Tab2"><label><offsets xml_i="34510" xml_f="34517" txt_i="21121" txt_f="21128">Table 2</offsets></label><caption><p><offsets xml_i="34537" xml_f="34557" txt_i="21128" txt_f="21148">Exercise description</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><th><offsets xml_i="34623" xml_f="34633" txt_i="21149" txt_f="21159">Brief name</offsets></th><th><offsets xml_i="34642" xml_f="34685" txt_i="21159" txt_f="21202">Home-based, knee-extensor strength exercise</offsets><break></break><offsets xml_i="34700" xml_f="34792" txt_i="21202" txt_f="21294">Detailed and practical demonstration of the exercise can be accessed via this online video [</offsets><xref ref-type="bibr" rid="CR30"><offsets xml_i="34825" xml_f="34827" txt_i="21294" txt_f="21296">30</offsets></xref><offsets xml_i="34834" xml_f="34836" txt_i="21296" txt_f="21298">] </offsets><inline-graphic xlink:href="13063_2017_2366_Figa_HTML.gif" id="d29e1021"></inline-graphic></th></tr></thead><tbody><tr><td><offsets xml_i="34959" xml_f="34976" txt_i="21298" txt_f="21315">1. Load magnitude</offsets></td><td><offsets xml_i="34985" xml_f="35029" txt_i="21316" txt_f="21360">Corresponding to 12 repetitions maximum (RM)</offsets></td></tr><tr><td><offsets xml_i="35047" xml_f="35071" txt_i="21361" txt_f="21385">2. Number of repetitions</offsets></td><td><offsets xml_i="35080" xml_f="35082" txt_i="21386" txt_f="21388">12</offsets></td></tr><tr><td><offsets xml_i="35100" xml_f="35117" txt_i="21389" txt_f="21406">3. Number of sets</offsets></td><td><offsets xml_i="35126" xml_f="35127" txt_i="21407" txt_f="21408">3</offsets></td></tr><tr><td><offsets xml_i="35145" xml_f="35165" txt_i="21409" txt_f="21429">4. Rest between sets</offsets></td><td><offsets xml_i="35174" xml_f="35237" txt_i="21430" txt_f="21493">Minimum 30 s, or until sufficiently recovered from previous set</offsets></td></tr><tr><td><offsets xml_i="35255" xml_f="35290" txt_i="21494" txt_f="21529">5. Number of exercise interventions</offsets></td><td><offsets xml_i="35299" xml_f="35328" txt_i="21530" txt_f="21559">Group 2 (2 sessions per week)</offsets><break></break><offsets xml_i="35343" xml_f="35372" txt_i="21559" txt_f="21588">Group 4 (4 sessions per week)</offsets><break></break><offsets xml_i="35387" xml_f="35416" txt_i="21588" txt_f="21617">Group 6 (6 sessions per week)</offsets></td></tr><tr><td><offsets xml_i="35434" xml_f="35472" txt_i="21618" txt_f="21656">6. Duration of the experimental period</offsets></td><td><offsets xml_i="35481" xml_f="35489" txt_i="21657" txt_f="21665">12 weeks</offsets></td></tr><tr><td><offsets xml_i="35507" xml_f="35619" txt_i="21666" txt_f="21778">7. Fractional and temporal distribution of the contraction modes per repetition and duration (s) of 1 repetition</offsets></td><td><offsets xml_i="35628" xml_f="35650" txt_i="21779" txt_f="21801">Concentric phase (3 s)</offsets><break></break><offsets xml_i="35665" xml_f="35686" txt_i="21801" txt_f="21822">Isometric phase (1 s)</offsets><break></break><offsets xml_i="35701" xml_f="35722" txt_i="21822" txt_f="21843">Eccentric phase (4 s)</offsets><break></break><offsets xml_i="35737" xml_f="35773" txt_i="21843" txt_f="21879">Total duration of 1 repetition (8 s)</offsets></td></tr><tr><td><offsets xml_i="35791" xml_f="35818" txt_i="21880" txt_f="21907">8. Rest between repetitions</offsets></td><td><offsets xml_i="35827" xml_f="35900" txt_i="21908" txt_f="21981">None, that is, right after finishing one repetition the next is commenced</offsets></td></tr><tr><td><offsets xml_i="35918" xml_f="35945" txt_i="21982" txt_f="22009">9. Time-under-tension (TUT)</offsets></td><td><offsets xml_i="35954" xml_f="35974" txt_i="22010" txt_f="22030">Repetition TUT (8 s)</offsets><break></break><offsets xml_i="35989" xml_f="36030" txt_i="22030" txt_f="22071">Set TUT with 12 repetitions (1 min, 36 s)</offsets><break></break><offsets xml_i="36045" xml_f="36096" txt_i="22071" txt_f="22122">Session TUT (3 sets × 12 repetitions) (4 min, 42 s)</offsets></td></tr><tr><td><offsets xml_i="36114" xml_f="36145" txt_i="22123" txt_f="22154">10. Volitional muscular failure</offsets></td><td><offsets xml_i="36154" xml_f="36536" txt_i="22155" txt_f="22537">No, but contractions should be continued until volitional muscular failure is very close. That is, until the knee-extensor muscles are maximally fatigued and the patient is not able to perform further repetitions. If volitional muscular failure occurs before the 12 RM, the resistance of the elastic band is adjusted so that the pre-determined number of repetitions can be completed</offsets></td></tr><tr><td><offsets xml_i="36554" xml_f="36573" txt_i="22538" txt_f="22557">11. Range of motion</offsets></td><td><offsets xml_i="36582" xml_f="36644" txt_i="22558" txt_f="22620">Starting position: 80–90° of knee flexion (0 = full extension)</offsets><break></break><offsets xml_i="36659" xml_f="36734" txt_i="22620" txt_f="22695">End-range of motion position: 0–10 (as close to full extension as possible)</offsets></td></tr><tr><td><offsets xml_i="36752" xml_f="36795" txt_i="22696" txt_f="22739">12. Recovery time between exercise sessions</offsets></td><td><offsets xml_i="36804" xml_f="36819" txt_i="22740" txt_f="22755">Group 2: 3 days</offsets><break></break><offsets xml_i="36834" xml_f="36848" txt_i="22755" txt_f="22769">Group 4: 1 day</offsets><break></break><offsets xml_i="36863" xml_f="36878" txt_i="22769" txt_f="22784">Group 6: 0 days</offsets></td></tr><tr><td><offsets xml_i="36896" xml_f="36953" txt_i="22785" txt_f="22842">13. Anatomical definition of the exercise (exercise form)</offsets></td><td><offsets xml_i="36962" xml_f="37449" txt_i="22843" txt_f="23330">The knee-extensor strength exercise is performed sitting in a stable chair. Sitting position in the chair is determined by the distance from the edge of the seat to the back of the knee; this distance should be 2–3 cm. If possible, the back rest can be used as well as the armrest. If the chair is without an armrest one can hold at the (side) edge of the seat. To ensure that the foot is free of the floor at 80–90° of flexion an object (e.g., a pillow) is placed under the thigh (Fig. </offsets><xref rid="Fig3" ref-type="fig"><offsets xml_i="37481" xml_f="37482" txt_i="23330" txt_f="23331">3</offsets></xref><offsets xml_i="37489" xml_f="37670" txt_i="23331" txt_f="23512">). The elastic exercise band is fixated to an immoveable object (e.g., an elastic exercise band anchor behind a closed door) and wrapped around the ankle of the exercised leg (Fig. </offsets><xref rid="Fig9" ref-type="fig"><offsets xml_i="37702" xml_f="37703" txt_i="23512" txt_f="23513">9</offsets></xref><offsets xml_i="37710" xml_f="37712" txt_i="23513" txt_f="23515">).</offsets><break></break><offsets xml_i="37727" xml_f="37817" txt_i="23515" txt_f="23605">Starting position: The exercise leg is relaxed with 80–90° of flexion (0 = full extension)</offsets><break></break><offsets xml_i="37832" xml_f="37931" txt_i="23605" txt_f="23704">Concentric phase: The exercise leg is extended as much as possible towards full extension using 3 s</offsets><break></break><offsets xml_i="37946" xml_f="38000" txt_i="23704" txt_f="23758">Isometric phase: The extended position is held for 1 s</offsets><break></break><offsets xml_i="38015" xml_f="38117" txt_i="23758" txt_f="23860">Eccentric phase: Slow controlled flexion of the knee joint (4 s) until the knee joint is flexed 80–90°</offsets><break></break><offsets xml_i="38132" xml_f="38217" txt_i="23860" txt_f="23945">These slow movements are chosen to ensure long time-under-tension (TUT) in the muscle</offsets></td></tr></tbody></table><table-wrap-foot><p><offsets xml_i="38263" xml_f="38406" txt_i="23946" txt_f="24089">The home-based, knee-extensor strength exercise described in detail according to the mechano-biological descriptors from Toigo and Boutellier [</offsets><xref ref-type="bibr" rid="CR31"><offsets xml_i="38439" xml_f="38441" txt_i="24089" txt_f="24091">31</offsets></xref><offsets xml_i="38448" xml_f="38449" txt_i="24091" txt_f="24092">]</offsets></p></table-wrap-foot></table-wrap></p></sec><sec id="Sec13"><title><offsets xml_i="38517" xml_f="38557" txt_i="24095" txt_f="24135">Criteria for modifying and discontinuing</offsets></title><sec id="Sec14"><title><offsets xml_i="38588" xml_f="38614" txt_i="24136" txt_f="24162">Criteria for discontinuing</offsets></title><p id="Par58"><offsets xml_i="38636" xml_f="38700" txt_i="24163" txt_f="24227">Patients are instructed to stop exercising if they experience a </offsets><italic><offsets xml_i="38708" xml_f="38723" txt_i="24227" txt_f="24242">strong flare up</offsets></italic><offsets xml_i="38732" xml_f="38738" txt_i="24242" txt_f="24248"> or a </offsets><italic><offsets xml_i="38746" xml_f="38764" txt_i="24248" txt_f="24266">strong aggravation</offsets></italic><offsets xml_i="38773" xml_f="39019" txt_i="24266" txt_f="24512"> of knee-related symptoms (e.g., pain and swelling), i.e., knee-related symptoms that are intolerable for the patient. Correspondingly, patients are encouraged to complete the exercise if they experience minor and moderate knee-related symptoms [</offsets><xref ref-type="bibr" rid="CR32"><offsets xml_i="39052" xml_f="39054" txt_i="24512" txt_f="24514">32</offsets></xref><offsets xml_i="39061" xml_f="39316" txt_i="24514" txt_f="24769">]. Should the patients experience intolerable symptoms (stopping with exercise); they are provided with a telephone number to a physiotherapist (the trial manager) and are encouraged to call. The trial manager fills out a standardized form at these calls.</offsets></p></sec><sec id="Sec15"><title><offsets xml_i="39349" xml_f="39371" txt_i="24771" txt_f="24793">Criteria for modifying</offsets></title><p id="Par59"><offsets xml_i="39393" xml_f="39653" txt_i="24794" txt_f="25054">Should the patients experience strong knee-related symptoms, they are instructed to lessen the resistance in the elastic exercise band (shortening the distance between the endpoints of the elastic exercise band, i.e., moving the chair closer to the door (Fig. </offsets><xref rid="Fig3" ref-type="fig"><offsets xml_i="39685" xml_f="39686" txt_i="25054" txt_f="25055">3</offsets></xref><offsets xml_i="39693" xml_f="40080" txt_i="25055" txt_f="25442">)). Importantly though is that this reduced resistance in the elastic exercise band does not comprise the exercise resistance corresponding to 12 RM, (i.e., too little resistance in the elastic exercise band). This is explained to the patients at the exercise instruction session and mentioned in the brochure handed to the patients along with the elastic exercise band (Additional file </offsets><xref rid="MOESM3" ref-type="media"><offsets xml_i="40116" xml_f="40117" txt_i="25442" txt_f="25443">3</offsets></xref><offsets xml_i="40124" xml_f="40126" txt_i="25443" txt_f="25445">).</offsets></p></sec></sec><sec id="Sec16"><title><offsets xml_i="40165" xml_f="40219" txt_i="25448" txt_f="25502">Participant compliance, retention and concomitant care</offsets></title><p id="Par60"><offsets xml_i="40241" xml_f="40587" txt_i="25503" txt_f="25849">At the baseline outcome assessment and at the exercise instruction session the patients are encouraged to complete the full intervention and the patients are handed an information brochure about both how to conduct the exercise, with encouragement to complete the intervention and with information on how to handle kinesiophobia (Additional file </offsets><xref rid="MOESM3" ref-type="media"><offsets xml_i="40623" xml_f="40624" txt_i="25849" txt_f="25850">3</offsets></xref><offsets xml_i="40631" xml_f="41196" txt_i="25850" txt_f="26415">). Further, the patients have two exercise quality check-up visits (booster visits): one at 4 weeks and one at 8 weeks, with the physiotherapist in the municipality setting. These booster visits also serve as promoters for exercise adherence. The patients should continue their lives without changing any concomitant care or interventions, except extra exercise of the quadriceps muscle. For pain relief the patients are allowed use of non-steroidal anti-inflammatory drugs (NSAIDs) and other pain-reducing products (cf. the Danish National Guidelines for knee OA [</offsets><xref ref-type="bibr" rid="CR3"><offsets xml_i="41228" xml_f="41229" txt_i="26415" txt_f="26416">3</offsets></xref><offsets xml_i="41236" xml_f="41306" txt_i="26416" txt_f="26486">]), as they would normally do, not needing a physician’s prescription.</offsets></p></sec><sec id="Sec17"><title><offsets xml_i="41339" xml_f="41347" txt_i="26488" txt_f="26496">Outcomes</offsets></title><p id="Par61"><offsets xml_i="41369" xml_f="41460" txt_i="26497" txt_f="26588">The trial is designed with four pre-determined outcome assessments; at baseline (week 0) (t</offsets><sub><offsets xml_i="41465" xml_f="41466" txt_i="26588" txt_f="26589">0</offsets></sub><offsets xml_i="41472" xml_f="41605" txt_i="26589" txt_f="26722">), after 12 weeks of home-based exercise (2–8 days after the final exercise session), corresponding to the endpoint before surgery (t</offsets><sub><offsets xml_i="41610" xml_f="41611" txt_i="26722" txt_f="26723">1</offsets></sub><offsets xml_i="41617" xml_f="41667" txt_i="26723" txt_f="26773">), at hospital discharge 1–8 days after surgery (t</offsets><sub><offsets xml_i="41672" xml_f="41673" txt_i="26773" txt_f="26774">2</offsets></sub><offsets xml_i="41679" xml_f="41751" txt_i="26774" txt_f="26846">) (provided surgery is performed) and finally, 3 months after surgery (t</offsets><sub><offsets xml_i="41756" xml_f="41757" txt_i="26846" txt_f="26847">3</offsets></sub><offsets xml_i="41763" xml_f="41771" txt_i="26847" txt_f="26855">) (Fig. </offsets><xref rid="Fig2" ref-type="fig"><offsets xml_i="41803" xml_f="41804" txt_i="26855" txt_f="26856">2</offsets></xref><offsets xml_i="41811" xml_f="41902" txt_i="26856" txt_f="26947">) (provided surgery is performed). The primary endpoint is after the intervention period (t</offsets><sub><offsets xml_i="41907" xml_f="41908" txt_i="26947" txt_f="26948">1</offsets></sub><offsets xml_i="41914" xml_f="42009" txt_i="26948" txt_f="27043">). Secondary endpoints of interest are just before hospital discharge 1–8 days after surgery (t</offsets><sub><offsets xml_i="42014" xml_f="42015" txt_i="27043" txt_f="27044">2</offsets></sub><offsets xml_i="42021" xml_f="42052" txt_i="27044" txt_f="27075">) and 3 months after surgery (t</offsets><sub><offsets xml_i="42057" xml_f="42058" txt_i="27075" txt_f="27076">3</offsets></sub><offsets xml_i="42064" xml_f="42066" txt_i="27076" txt_f="27078">).</offsets></p><sec id="Sec18"><title><offsets xml_i="42093" xml_f="42108" txt_i="27079" txt_f="27094">Primary outcome</offsets></title><p id="Par62"><offsets xml_i="42130" xml_f="42672" txt_i="27095" txt_f="27634">Change in isometric knee-extensor strength from baseline (week 0) to after the intervention period (&gt; 12 weeks). Knee-extensor strength is chosen as the primary outcome for the following reasons. Firstly, it is an outcome closely related to the exposure (strength training), which we consider important in a dose-response trial, because other health effects are likely mediated via increased knee-extensor strength. Secondly, knee-extensor strength is associated with the development and progression of knee OA and knee pain and function [</offsets><xref ref-type="bibr" rid="CR9"><offsets xml_i="42704" xml_f="42705" txt_i="27634" txt_f="27635">9</offsets></xref><offsets xml_i="42712" xml_f="42714" txt_i="27635" txt_f="27637">, </offsets><xref ref-type="bibr" rid="CR10"><offsets xml_i="42747" xml_f="42749" txt_i="27637" txt_f="27639">10</offsets></xref><offsets xml_i="42756" xml_f="42893" txt_i="27639" txt_f="27776">], and as such, we also consider the outcome, a surrogate measure for the development and progression of knee OA, knee pain and function.</offsets></p></sec><sec id="Sec19"><title><offsets xml_i="42926" xml_f="42944" txt_i="27778" txt_f="27796">Secondary outcomes</offsets></title><p id="Par63"><offsets xml_i="42966" xml_f="43272" txt_i="27797" txt_f="28103">Change in performance-based function (walking distance in 6 min and climbing of stairs), current knee pain and during the last week (numerical rating scale), self-reported disability (Knee Osteoarthritis Outcome Score and Oxford Knee Score) as recommended by Osteoarthritis Research Society International [</offsets><xref ref-type="bibr" rid="CR33"><offsets xml_i="43305" xml_f="43307" txt_i="28103" txt_f="28105">33</offsets></xref><offsets xml_i="43314" xml_f="43316" txt_i="28105" txt_f="28107">, </offsets><xref ref-type="bibr" rid="CR34"><offsets xml_i="43349" xml_f="43351" txt_i="28107" txt_f="28109">34</offsets></xref><offsets xml_i="43358" xml_f="43429" txt_i="28109" txt_f="28180">], need for surgery and exercise adherence (sessions, sets, reps, TUT).</offsets></p></sec><sec id="Sec20"><title><offsets xml_i="43462" xml_f="43476" txt_i="28182" txt_f="28196">Other outcomes</offsets></title><p id="Par64"><offsets xml_i="43498" xml_f="43605" txt_i="28197" txt_f="28304">Registration of adverse events (adverse event, number of adverse events in each group (surgery/no surgery).</offsets></p><p id="Par65"><offsets xml_i="43623" xml_f="43655" txt_i="28305" txt_f="28337">At outcome assessment endpoint t</offsets><sub><offsets xml_i="43660" xml_f="43661" txt_i="28337" txt_f="28338">2</offsets></sub><offsets xml_i="43667" xml_f="43724" txt_i="28338" txt_f="28395"> (after surgery at hospital discharge) only the outcomes </offsets><italic><offsets xml_i="43732" xml_f="43799" txt_i="28395" txt_f="28462">isometric knee-extensor strength, 6-Minute Walking Test (6MWT), SCT</offsets></italic><offsets xml_i="43808" xml_f="43813" txt_i="28462" txt_f="28467"> and </offsets><italic><offsets xml_i="43821" xml_f="43838" txt_i="28467" txt_f="28484">current knee pain</offsets></italic><offsets xml_i="43847" xml_f="43866" txt_i="28484" txt_f="28503"> are assessed. The </offsets><italic><offsets xml_i="43874" xml_f="43878" txt_i="28503" txt_f="28507">KOOS</offsets></italic><offsets xml_i="43887" xml_f="43892" txt_i="28507" txt_f="28512"> and </offsets><italic><offsets xml_i="43900" xml_f="43903" txt_i="28512" txt_f="28515">OKS</offsets></italic><offsets xml_i="43912" xml_f="43939" txt_i="28515" txt_f="28542"> questionnaires as well as </offsets><italic><offsets xml_i="43947" xml_f="43977" txt_i="28542" txt_f="28572">knee pain during the last week</offsets></italic><offsets xml_i="43986" xml_f="44118" txt_i="28572" txt_f="28704"> are omitted at this endpoint as they are not validated to assess acute post-operative conditions, and use too long a recall period.</offsets></p></sec></sec><sec id="Sec21"><title><offsets xml_i="44157" xml_f="44199" txt_i="28707" txt_f="28749">Elaborated description of outcome measures</offsets></title><sec id="Sec22"><title><offsets xml_i="44230" xml_f="44245" txt_i="28750" txt_f="28765">Primary outcome</offsets></title><sec id="FPar1"><title><offsets xml_i="44276" xml_f="44308" txt_i="28766" txt_f="28798">Isometric knee-extensor strength</offsets></title><p id="Par66"><offsets xml_i="44330" xml_f="44664" txt_i="28799" txt_f="29130">The measurement will be assessed using a computerized strength chair (Good Strength Chair, Metitur Oy, Jyvaskyla, Finland). This is a valid (0.78–0.92) and reliable (inter-trial 0.98–1.00 (standard error of measurement (SEM) &lt; 10%), inter-evaluator 0.92–0.99 (SEM 8.34–9.92%)) knee-extensor strength measure in the TKA population [</offsets><xref ref-type="bibr" rid="CR35"><offsets xml_i="44697" xml_f="44699" txt_i="29130" txt_f="29132">35</offsets></xref><offsets xml_i="44706" xml_f="44708" txt_i="29132" txt_f="29134">].</offsets></p><p id="Par67"><offsets xml_i="44726" xml_f="45491" txt_i="29135" txt_f="29900">Prior to outcome assessment, the patients will be informed about the procedure. The measurement consists of five maximal isometric knee-extensor contractions at 60° knee flexion separated by a 60-s pauses. The highest obtained value will be used for analysis. The patients are instructed to extend their knee as forcefully as possible with a gradual increase in force over a 5-s period. There will be strong and standardized verbal encouragement during each contraction. Knee-extensor strength will subsequently be expressed as the maximal voluntary torque per kilogram body mass (Nm/kg) using the external lever arm and body mass of each patient. Results will be presented, firstly, as absolute changes (Nm/kg) and, secondly, as relative changes (%) from baseline.</offsets></p></sec></sec><sec id="Sec23"><title><offsets xml_i="45530" xml_f="45548" txt_i="29903" txt_f="29921">Secondary outcomes</offsets></title><sec id="FPar2"><title><offsets xml_i="45579" xml_f="45620" txt_i="29922" txt_f="29963">6-Minute Walking Test for distance (6MWT)</offsets></title><p id="Par68"><offsets xml_i="45642" xml_f="45867" txt_i="29964" txt_f="30189">The 6MWT measures the maximal distance a patient is able to walk in 6 min between two cones placed 29 m apart from each other. The measurement has previously been found to be reliable (intraclass correlation coefficient (ICC)</offsets><sub><offsets xml_i="45872" xml_f="45875" txt_i="30189" txt_f="30192">2,1</offsets></sub><offsets xml_i="45881" xml_f="45901" txt_i="30192" txt_f="30212"> 0.97, SEM 13.0 m) [</offsets><xref ref-type="bibr" rid="CR36"><offsets xml_i="45934" xml_f="45936" txt_i="30212" txt_f="30214">36</offsets></xref><offsets xml_i="45943" xml_f="45961" txt_i="30214" txt_f="30232">] and responsive [</offsets><xref ref-type="bibr" rid="CR37"><offsets xml_i="45994" xml_f="45996" txt_i="30232" txt_f="30234">37</offsets></xref><offsets xml_i="46003" xml_f="46027" txt_i="30234" txt_f="30258">] in the TKA population.</offsets></p><p id="Par69"><offsets xml_i="46045" xml_f="46429" txt_i="30259" txt_f="30643">The patients are instructed to walk as long a distance as they can in six minutes. They will be encouraged to walk as fast as possible but are not allowed to jog or run. The patients are allowed to rest standing or leaning against a wall during the six minutes but the time will be running. Walking aids are allowed if needed. At each minute the patients will be informed of the time.</offsets></p></sec><sec id="FPar3"><title><offsets xml_i="46462" xml_f="46484" txt_i="30645" txt_f="30667">Stair Climb Test (SCT)</offsets></title><p id="Par70"><offsets xml_i="46506" xml_f="46742" txt_i="30668" txt_f="30904">The SCT measures the time (seconds) it takes to ascend and descend an 11-step flight of stairs with 16-cm step height. The stair has a handrail on both sides. The SCT has been found to be reliable in the TKA population (inter-tester ICC</offsets><sub><offsets xml_i="46747" xml_f="46750" txt_i="30904" txt_f="30907">2,1</offsets></sub><offsets xml_i="46756" xml_f="46811" txt_i="30907" txt_f="30962"> 0.94–0.96, SEM 1.14 s, minimal detectable change (MDC)</offsets><sub><offsets xml_i="46816" xml_f="46818" txt_i="30962" txt_f="30964">90</offsets></sub><offsets xml_i="46824" xml_f="46833" txt_i="30964" txt_f="30973"> 2.6 s) [</offsets><xref ref-type="bibr" rid="CR38"><offsets xml_i="46866" xml_f="46868" txt_i="30973" txt_f="30975">38</offsets></xref><offsets xml_i="46875" xml_f="47129" txt_i="30975" txt_f="31229">]. The patients are instructed to ascend and descend an 11-step flight of stairs as fast as possible, but in a safe manner. Use of hand rail and walking aid is permitted. The patients are allowed to rest during the measurement but the time keeps running.</offsets></p></sec><sec id="FPar4"><title><offsets xml_i="47162" xml_f="47202" txt_i="31231" txt_f="31271">Knee Osteoarthritis Outcome Score (KOOS)</offsets></title><p id="Par71"><offsets xml_i="47224" xml_f="47917" txt_i="31272" txt_f="31965">The KOOS is a 42-item questionnaire regarding knee function. The questionnaire is comprised of five subscales (symptoms (7), pain (9), function, daily living (17), function, sports and recreational activities (5) and quality of life (4). Each question has standardized answer options with five options at each question (Likert scale, 0–4). After normalization of the answers each subscale scores from 0–100 (100 indicating no symptoms). The KOOS questionnaire is found to be reliable in all subscales (pain ICC 0.8–0.97, SEM 7.2–10.2; symptoms ICC 0.74–0.94, SEM 7.2–9.0; daily living ICC 0.84–0.94, SEM 5.2–11.7; sports ICC 0.65–0.92, SEM 9–24.6; quality of life ICC 0.6–0.91, SEM 7.4–10.8) [</offsets><xref ref-type="bibr" rid="CR39"><offsets xml_i="47950" xml_f="47952" txt_i="31965" txt_f="31967">39</offsets></xref><offsets xml_i="47959" xml_f="48037" txt_i="31967" txt_f="32045">]. The KOOS questionnaire is also found be to reliable in the TKA population [</offsets><xref ref-type="bibr" rid="CR40"><offsets xml_i="48070" xml_f="48072" txt_i="32045" txt_f="32047">40</offsets></xref><offsets xml_i="48079" xml_f="48081" txt_i="32047" txt_f="32049">].</offsets></p></sec><sec id="FPar5"><title><offsets xml_i="48114" xml_f="48137" txt_i="32051" txt_f="32074">Oxford Knee Score (OKS)</offsets></title><p id="Par72"><offsets xml_i="48159" xml_f="48411" txt_i="32075" txt_f="32327">The OKS is a 12-item questionnaire regarding knee-related function and pain in patients with knee OA. Each question has five answer options (Likert scale, 0–4). The OKS demonstrates good test-retest reliability for both the summary scale (ICC 0.93, MDC</offsets><sub><offsets xml_i="48416" xml_f="48418" txt_i="32327" txt_f="32329">90</offsets></sub><offsets xml_i="48424" xml_f="48450" txt_i="32329" txt_f="32355"> + 6), pain (ICC 0.91, MDC</offsets><sub><offsets xml_i="48455" xml_f="48457" txt_i="32355" txt_f="32357">90</offsets></sub><offsets xml_i="48463" xml_f="48497" txt_i="32357" txt_f="32391"> ± 16) and function (ICC 0.92, MDC</offsets><sub><offsets xml_i="48502" xml_f="48504" txt_i="32391" txt_f="32393">90</offsets></sub><offsets xml_i="48510" xml_f="48538" txt_i="32393" txt_f="32421"> ± 15) component subscales [</offsets><xref ref-type="bibr" rid="CR41"><offsets xml_i="48571" xml_f="48573" txt_i="32421" txt_f="32423">41</offsets></xref><offsets xml_i="48580" xml_f="48582" txt_i="32423" txt_f="32425">].</offsets></p></sec><sec id="FPar6"><title><offsets xml_i="48615" xml_f="48624" txt_i="32427" txt_f="32436">Knee pain</offsets></title><p id="Par73"><offsets xml_i="48646" xml_f="49519" txt_i="32437" txt_f="33310">Individual knee pain is assessed with the Numeric Rating Scale (NRS). This is an 11-point subjective pain scale ranging from 0–10 (0 indicating no pain). In this trial, the patients will be asked about their knee pain related to two endpoints: (1) knee pain right now and (2) during the last week. The question is asked in the following manner “on a scale from 0 to 10 where 0 indicates no pain and 10 indicates worst imaginable pain, how much knee pain do you have (1) right now and (2) how much knee pain have you had in the last week (index knee)?” The patients are asked while seated in a chair with 70–90° of knee flexion (standardized). The NRS is found to have the strongest face validity compared to other pain measurement scales (Visual Analog Scale and Verbal Descriptor Scale) in surgical patients after surgery as well as high construct and criterion validity [</offsets><xref ref-type="bibr" rid="CR42"><offsets xml_i="49552" xml_f="49554" txt_i="33310" txt_f="33312">42</offsets></xref><offsets xml_i="49561" xml_f="49687" txt_i="33312" txt_f="33438">]. The NRS is also found to be reliable both before (ICC 0.82) and in the first 1–6 days following surgery (ICC 0.673–0.783) [</offsets><xref ref-type="bibr" rid="CR43"><offsets xml_i="49720" xml_f="49722" txt_i="33438" txt_f="33440">43</offsets></xref><offsets xml_i="49729" xml_f="49854" txt_i="33440" txt_f="33565">]. A minimal clinically important difference in pain relief post orthopedic surgery has previously been suggested to be 35% [</offsets><xref ref-type="bibr" rid="CR44"><offsets xml_i="49887" xml_f="49889" txt_i="33565" txt_f="33567">44</offsets></xref><offsets xml_i="49896" xml_f="49898" txt_i="33567" txt_f="33569">].</offsets></p></sec><sec id="FPar7"><title><offsets xml_i="49931" xml_f="49966" txt_i="33571" txt_f="33606">Surgical status – Need for surgery?</offsets></title><p id="Par74"><offsets xml_i="49988" xml_f="50058" txt_i="33607" txt_f="33677">At the second outcome assessment (after the 12-week exercise period (t</offsets><sub><offsets xml_i="50063" xml_f="50064" txt_i="33677" txt_f="33678">1</offsets></sub><offsets xml_i="50070" xml_f="50121" txt_i="33678" txt_f="33729">)) the patients are asked by the outcome assessor “</offsets><italic><offsets xml_i="50129" xml_f="50215" txt_i="33729" txt_f="33815">based on your knee symptoms in the last week would you say that you need knee surgery?</offsets></italic><offsets xml_i="50224" xml_f="50370" txt_i="33815" txt_f="33961">” The outcome assessor is a physiotherapist with insight to the knee OA condition. The answer will be categorized into one of three options: (1) “</offsets><italic><offsets xml_i="50378" xml_f="50381" txt_i="33961" txt_f="33964">yes</offsets></italic><offsets xml_i="50390" xml_f="50392" txt_i="33964" txt_f="33966">” </offsets><italic><offsets xml_i="50400" xml_f="50424" txt_i="33966" txt_f="33990">I believe I need surgery</offsets></italic><offsets xml_i="50433" xml_f="50439" txt_i="33990" txt_f="33996">, (2) </offsets><italic><offsets xml_i="50447" xml_f="50460" txt_i="33996" txt_f="34009">I do not know</offsets></italic><offsets xml_i="50469" xml_f="50478" txt_i="34009" txt_f="34018"> or (3) “</offsets><italic><offsets xml_i="50486" xml_f="50488" txt_i="34018" txt_f="34020">no</offsets></italic><offsets xml_i="50497" xml_f="50499" txt_i="34020" txt_f="34022">” </offsets><italic><offsets xml_i="50507" xml_f="50538" txt_i="34022" txt_f="34053">I do not believe I need surgery</offsets></italic><offsets xml_i="50547" xml_f="50548" txt_i="34053" txt_f="34054">.</offsets></p></sec><sec id="FPar8"><title><offsets xml_i="50581" xml_f="50599" txt_i="34056" txt_f="34074">Exercise adherence</offsets></title><p id="Par75"><offsets xml_i="50621" xml_f="50734" txt_i="34075" txt_f="34188">A large challenge regarding home-based exercise is that adherence to home-based exercise is reported to be poor [</offsets><xref ref-type="bibr" rid="CR45"><offsets xml_i="50767" xml_f="50769" txt_i="34188" txt_f="34190">45</offsets></xref><offsets xml_i="50776" xml_f="50777" txt_i="34190" txt_f="34191">–</offsets><xref ref-type="bibr" rid="CR48"><offsets xml_i="50810" xml_f="50812" txt_i="34191" txt_f="34193">48</offsets></xref><offsets xml_i="50819" xml_f="51466" txt_i="34193" txt_f="34840">], suggesting low effect of the exercise interventions. To take into account the possibility of non-adherence to the intervention (which could distort the possible conclusion that the intervention did not work), we will objectively quantify exercise adherence. Adherence to the home-based, single knee-extensor strength exercise will be assessed using a sensor (BandCizer technology) attached to the elastic exercise band used for the knee-extensor strength exercise. The sensor stores data on date, time, number of sets, repetitions, tonnage (kg × repetitions) and TUT. This elastic exercise band sensor technology has been reported to be valid [</offsets><xref ref-type="bibr" rid="CR49"><offsets xml_i="51499" xml_f="51501" txt_i="34840" txt_f="34842">49</offsets></xref><offsets xml_i="51508" xml_f="51540" txt_i="34842" txt_f="34871">] and reliable (ICC &gt; 0.99) [</offsets><xref ref-type="bibr" rid="CR50"><offsets xml_i="51573" xml_f="51575" txt_i="34871" txt_f="34873">50</offsets></xref><offsets xml_i="51582" xml_f="51712" txt_i="34873" txt_f="35003">] for quantification of total repetition, single repetition and contraction specific TUT of an unsupervised exercise intervention.</offsets></p><p id="Par76"><offsets xml_i="51730" xml_f="52406" txt_i="35004" txt_f="35677">In the present trial, patients are defined as adherent to the exercise intervention if &gt; 75% of the prescribed exercise sessions are completed. Correspondingly, 1.5 sessions/week must be completed in group 2, three sessions/week in group 4 and 4.5 sessions/week in group 6. After the 12-week exercise period, the patients who undergo surgery are encouraged to continue exercising (same dosage) until the day of surgery. The exercise adherence during this period will also be quantified by use of the sensor. Patients deciding not to undergo surgery following the 12 weeks of exercise are encouraged to keep exercising, but exercise adherence will not be quantified. Figure </offsets><xref rid="Fig4" ref-type="fig"><offsets xml_i="52438" xml_f="52439" txt_i="35677" txt_f="35678">4</offsets></xref><offsets xml_i="52446" xml_f="52918" txt_i="35678" txt_f="36150"> shows an example of objectively quantified exercise adherence via the sensor attached to the elastic exercise band. The example shows a knee-extensor strength exercise session composed of three sets with 12 repetitions in each set resulting in 36 repetitions in total for the exercise session. Number of repetitions, total TUT, mean TUT for the 36 repetition and the corresponding standard deviation can be extracted. This is also possible for single exercise sets (Fig. </offsets><xref rid="Fig5" ref-type="fig"><offsets xml_i="52950" xml_f="52951" txt_i="36150" txt_f="36151">5</offsets></xref><offsets xml_i="52958" xml_f="52960" txt_i="36151" txt_f="36153">).</offsets><fig id="Fig4"><label><offsets xml_i="52982" xml_f="52988" txt_i="36153" txt_f="36159">Fig. 4</offsets></label><caption><p><offsets xml_i="53008" xml_f="53122" txt_i="36159" txt_f="36273">Objective quantification of exercise adherence for a full exercise session comprising three sets of 12 repetitions</offsets></p></caption><graphic xlink:href="13063_2017_2366_Fig4_HTML" id="MO4"></graphic></fig><fig id="Fig5"><label><offsets xml_i="53231" xml_f="53237" txt_i="36274" txt_f="36280">Fig. 5</offsets></label><caption><p><offsets xml_i="53257" xml_f="53347" txt_i="36280" txt_f="36370">Objective quantification of exercise adherence for a single exercise set of 12 repetitions</offsets></p></caption><graphic xlink:href="13063_2017_2366_Fig5_HTML" id="MO5"></graphic></fig></p></sec><sec id="FPar9"><title><offsets xml_i="53467" xml_f="53481" txt_i="36373" txt_f="36387">Adverse events</offsets></title><p id="Par77"><offsets xml_i="53503" xml_f="54033" txt_i="36388" txt_f="36918">All adverse events occurring while the patients are enrolled in the trial will be recorded regardless of their relation to the exercise intervention, surgery or occurrence likely not related to the trial. Thus, an adverse event can both be a negative effect of the intervention, surgery or an occurrence not related to the trial, that is an untoward occurrence during the trial which may or may not causally related to the intervention or trial. Regardless of a relation to the trial, all adverse events are recorded and reported.</offsets></p><p id="Par78"><offsets xml_i="54051" xml_f="55224" txt_i="36919" txt_f="38092">Finally, a qualitative study will be embedded in the trial. Semi-structured interviews will be performed with randomly selected participating patients both before and after the trial about their experienced enablers and barriers related to the knee-extensor strength exercise and adherence to the home-based intervention. The orthopedic surgeons allocated to the trial will also undergo semi-structured interviews about their experienced enablers and barriers with the non-surgical, pre-operative, home-based intervention both before and after the trial. The physiotherapists allocated to the trial will undergo focus interviews, both before the trial is commenced and once the trial is completed, to explore their experienced enablers and barriers related to administering the home-based intervention. This embedded qualitative study is undertaken to refine the home-based intervention for future trials and clinical implementation. This knowledge can then be used to design a context-specific implementation plan, given a positive trial outcome. The embedded qualitative study will be reported in a separate qualitative paper, with a clear reference to the QUADX-1 trial.</offsets></p><p id="Par79"><offsets xml_i="55242" xml_f="55543" txt_i="38093" txt_f="38394">Regular auditing is planned during the trial. Regular meetings between the primary investigator, the orthopedic department, the municipalities and the research team will allow for checking of treatment notes and outcome assessment forms for fidelity to protocol which allows for addressing deviations.</offsets></p></sec></sec></sec><sec id="Sec24"><title><offsets xml_i="55588" xml_f="55599" txt_i="38398" txt_f="38409">Sample size</offsets></title><p id="Par80"><offsets xml_i="55621" xml_f="55822" txt_i="38410" txt_f="38611">For a three-group-level One-way ANOVA of a normal mean difference with a two-sided significance level of 0.05, a common standard deviation of 0.22 Nm/kg (isometric knee-extensor strength measurement) [</offsets><xref ref-type="bibr" rid="CR51"><offsets xml_i="55855" xml_f="55857" txt_i="38611" txt_f="38613">51</offsets></xref><offsets xml_i="55864" xml_f="56153" txt_i="38613" txt_f="38902">], and a minimal clinically important difference of 0.15 Nm/kg (15%), a sample size of 126 (42 per group) patients is required to obtain a power of 80%. To allow for a dropout rate of 10%, we will include 140 patients in total for the intention-to-treat (ITT) analysis (3 × 42 + 14 = 140).</offsets></p></sec><sec id="Sec25"><title><offsets xml_i="56186" xml_f="56199" txt_i="38904" txt_f="38917">Randomization</offsets></title><p id="Par81"><offsets xml_i="56221" xml_f="56915" txt_i="38918" txt_f="39612">The patients will be randomly assigned to one of the three intervention groups (two, four or six sessions per week) by a 1:1:1 allocation ratio. The generation of the allocation sequence will be attended to by a statistician not involved in the trial in any other way. One hundred and forty opaque and sealed envelopes will be generated. After being included in the trial (signed written informed consent and completion of baseline assessment) a person independent of the trial will open one of these envelopes and inform the patient’s municipality which of the three exercise groups the patient is allocated to. In this way, the allocation information is kept secret from the outcome assessor.</offsets></p></sec><sec id="Sec26"><title><offsets xml_i="56948" xml_f="56956" txt_i="39614" txt_f="39622">Blinding</offsets></title><p id="Par82"><offsets xml_i="56978" xml_f="57924" txt_i="39623" txt_f="40569">The primary investigator collecting the outcomes (outcome assessor) as well as the data analysts will be blinded to allocation. At outcome assessment sessions, the outcome assessor will start by informing the patients that they are not allowed to mention what exercise dosage they have received. The data will be coded in such a way that group allocation is concealed in the dataset, thus blinding the outcome assessors and data analysts to the group allocation. The patients and the physiotherapists instructing in the intervention will not be blinded due to the nature of the intervention; however, the patients will be blinded to the exercise dosages in the other groups, which exercise dosages will be compared in the analysis and which dosage is hypothesized to have the largest effect. Unblinding will only happen in the case where the wellbeing a the patient is at risk. This will be assessed in collaboration with the patient’s physician.</offsets></p></sec><sec id="Sec27"><title><offsets xml_i="57957" xml_f="57972" txt_i="40571" txt_f="40586">Data management</offsets></title><p id="Par83"><offsets xml_i="57994" xml_f="58506" txt_i="40587" txt_f="41099">Data from the isometric knee-extensor strength assessment are stored on a computer dedicated to the Metitur equipment as well as being recorded in handwriting in a standardized Case Report Form. The self-reported questionnaires (KOOS and OKS) will be filled in by the patients in paper formats, as this is the way these questionnaires are designed to be filled in. All data from the functional (6MWT and SCT) and pain (NRS) assessments will be recorded on a standardized Case Report Form by the outcome assessor.</offsets></p><p id="Par84"><offsets xml_i="58524" xml_f="58808" txt_i="41100" txt_f="41384">Data on exercise adherence from the sensors is saved continuously on the built-in SD card. After the intervention period, the sensors are collected and the exercise data are transferred by Bluetooth from the SD card onto a secure server. The device will not contain any personal data.</offsets></p><p id="Par85"><offsets xml_i="58826" xml_f="59498" txt_i="41385" txt_f="42057">Following all outcome assessments, data will be entered into the browser-based research database Research Electronic Data Capture (RedCap 7.1.1) by trial personal using blinded double-data entry to ensure data quality. To further ensure the integrity of the data, anonymous ID numbers will be applied and data quality, data range and data values will be checked to minimize typing errors. All original written information and case report forms will be stored in a secure locker and saved for 3 after the completion of the trial at the trial location. All electronic data will be anonymous (patient IDs), coded and saved on a secure server in the Capital Region of Denmark.</offsets></p></sec><sec id="Sec28"><title><offsets xml_i="59531" xml_f="59551" txt_i="42059" txt_f="42079">Statistical analysis</offsets></title><sec id="Sec29"><title><offsets xml_i="59582" xml_f="59598" txt_i="42080" txt_f="42096">Analysis outline</offsets></title><p id="Par86"><offsets xml_i="59620" xml_f="59898" txt_i="42097" txt_f="42375">Three groups; group 2 = two sessions/week, group 4 = four sessions/week and group 6 = six sessions/week. There is no control group. The primary outcome is the change in isometric knee-extensor strength. Time from baseline to after 12 weeks of exercise is the primary endpoint (Δ</offsets><sub><offsets xml_i="59903" xml_f="59908" txt_i="42375" txt_f="42380">t0-t1</offsets></sub><offsets xml_i="59914" xml_f="60053" txt_i="42380" txt_f="42519">) and time from baseline to just before hospital discharge, and time from baseline to 3 months after surgery are the secondary endpoints (Δ</offsets><sub><offsets xml_i="60058" xml_f="60063" txt_i="42519" txt_f="42524">t0-t2</offsets></sub><offsets xml_i="60069" xml_f="60075" txt_i="42524" txt_f="42530"> and Δ</offsets><sub><offsets xml_i="60080" xml_f="60085" txt_i="42530" txt_f="42535">t0-t3</offsets></sub><offsets xml_i="60091" xml_f="60188" txt_i="42535" txt_f="42632">, respectively). The analysis plans for the primary and secondary analyses are outlined in Table </offsets><xref rid="Tab3" ref-type="table"><offsets xml_i="60222" xml_f="60223" txt_i="42632" txt_f="42633">3</offsets></xref><offsets xml_i="60230" xml_f="60231" txt_i="42633" txt_f="42634">.</offsets><table-wrap id="Tab3"><label><offsets xml_i="60260" xml_f="60267" txt_i="42634" txt_f="42641">Table 3</offsets></label><caption><p><offsets xml_i="60287" xml_f="60338" txt_i="42641" txt_f="42692">Analysis outline for primary and secondary analysis</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><th><offsets xml_i="60404" xml_f="60420" txt_i="42693" txt_f="42709">Variable/outcome</offsets></th><th><offsets xml_i="60429" xml_f="60439" txt_i="42709" txt_f="42719">Hypothesis</offsets></th><th><offsets xml_i="60448" xml_f="60477" txt_i="42719" txt_f="42748">Outcome measure (unit, scale)</offsets></th><th><offsets xml_i="60486" xml_f="60505" txt_i="42748" txt_f="42767">Methods of analysis</offsets></th></tr></thead><tbody><tr><td><offsets xml_i="60538" xml_f="60585" txt_i="42767" txt_f="42814">Descriptive statistics (sample characteristics)</offsets></td><td></td><td><offsets xml_i="60603" xml_f="60671" txt_i="42816" txt_f="42884">Age, weight, height, side of index knee (continuous and dichotomous)</offsets></td><td><offsets xml_i="60680" xml_f="60698" txt_i="42885" txt_f="42903">Summary statistics</offsets></td></tr><tr><td colspan="4"><offsets xml_i="60728" xml_f="60744" txt_i="42904" txt_f="42920">Primary analysis</offsets></td></tr><tr><td colspan="4"><offsets xml_i="60774" xml_f="60790" txt_i="42921" txt_f="42937"> Primary outcome</offsets></td></tr><tr><td><offsets xml_i="60808" xml_f="60821" txt_i="42938" txt_f="42951">1. Change in </offsets><italic><offsets xml_i="60829" xml_f="60861" txt_i="42951" txt_f="42983">isometric knee-extensor strength</offsets></italic><offsets xml_i="60870" xml_f="60872" txt_i="42983" txt_f="42985"> Δ</offsets><sub><offsets xml_i="60877" xml_f="60882" txt_i="42985" txt_f="42990">t0-t1</offsets></sub></td><td><offsets xml_i="60897" xml_f="60917" txt_i="42991" txt_f="43008">Group 2 &lt; Group 4</offsets><break></break><offsets xml_i="60932" xml_f="60949" txt_i="43008" txt_f="43025">Group 4 ≈ Group 6</offsets></td><td><offsets xml_i="60958" xml_f="60986" txt_i="43026" txt_f="43054">Change in Nm/kg (continuous)</offsets></td><td><offsets xml_i="60995" xml_f="61021" txt_i="43055" txt_f="43081">Analysis of variance ANOVA</offsets><sup><offsets xml_i="61026" xml_f="61027" txt_i="43081" txt_f="43082">a</offsets></sup></td></tr><tr><td colspan="4"><offsets xml_i="61063" xml_f="61081" txt_i="43083" txt_f="43101">Secondary analysis</offsets></td></tr><tr><td colspan="4"><offsets xml_i="61111" xml_f="61130" txt_i="43102" txt_f="43121"> Secondary outcomes</offsets></td></tr><tr><td><offsets xml_i="61148" xml_f="61161" txt_i="43122" txt_f="43135">2. Change in </offsets><italic><offsets xml_i="61169" xml_f="61201" txt_i="43135" txt_f="43167">isometric knee-extensor strength</offsets></italic><offsets xml_i="61210" xml_f="61212" txt_i="43167" txt_f="43169"> Δ</offsets><sub><offsets xml_i="61217" xml_f="61222" txt_i="43169" txt_f="43174">t0-t2</offsets></sub><offsets xml_i="61228" xml_f="61231" txt_i="43174" txt_f="43177">, Δ</offsets><sub><offsets xml_i="61236" xml_f="61241" txt_i="43177" txt_f="43182">t0-t3</offsets></sub></td><td><offsets xml_i="61256" xml_f="61276" txt_i="43183" txt_f="43200">Group 2 &lt; Group 4</offsets><break></break><offsets xml_i="61291" xml_f="61308" txt_i="43200" txt_f="43217">Group 4 ≈ Group 6</offsets></td><td><offsets xml_i="61317" xml_f="61345" txt_i="43218" txt_f="43246">Change in Nm/kg (continuous)</offsets></td><td><offsets xml_i="61354" xml_f="61359" txt_i="43247" txt_f="43252">ANOVA</offsets><sup><offsets xml_i="61364" xml_f="61365" txt_i="43252" txt_f="43253">a</offsets></sup></td></tr><tr><td><offsets xml_i="61389" xml_f="61402" txt_i="43254" txt_f="43267">3. Change in </offsets><italic><offsets xml_i="61410" xml_f="61443" txt_i="43267" txt_f="43300">Knee Osteoarthritis Outcome Score</offsets></italic><offsets xml_i="61452" xml_f="61471" txt_i="43300" txt_f="43319"> (KOOS) subscales Δ</offsets><sub><offsets xml_i="61476" xml_f="61481" txt_i="43319" txt_f="43324">t0-t1</offsets></sub><offsets xml_i="61487" xml_f="61490" txt_i="43324" txt_f="43327">, Δ</offsets><sub><offsets xml_i="61495" xml_f="61500" txt_i="43327" txt_f="43332">t0-t3</offsets></sub></td><td><offsets xml_i="61515" xml_f="61535" txt_i="43333" txt_f="43350">Group 2 &lt; Group 4</offsets><break></break><offsets xml_i="61550" xml_f="61570" txt_i="43350" txt_f="43367">Group 4 &gt; Group 6</offsets></td><td><offsets xml_i="61579" xml_f="61625" txt_i="43368" txt_f="43414">Change in questionnaire subscales (continuous)</offsets></td><td><offsets xml_i="61634" xml_f="61639" txt_i="43415" txt_f="43420">ANOVA</offsets><sup><offsets xml_i="61644" xml_f="61645" txt_i="43420" txt_f="43421">a</offsets></sup></td></tr><tr><td><offsets xml_i="61669" xml_f="61682" txt_i="43422" txt_f="43435">4. Change in </offsets><italic><offsets xml_i="61690" xml_f="61707" txt_i="43435" txt_f="43452">Oxford Knee Score</offsets></italic><offsets xml_i="61716" xml_f="61724" txt_i="43452" txt_f="43460"> (OKS) Δ</offsets><sub><offsets xml_i="61729" xml_f="61734" txt_i="43460" txt_f="43465">t0-t1</offsets></sub><offsets xml_i="61740" xml_f="61743" txt_i="43465" txt_f="43468">, Δ</offsets><sub><offsets xml_i="61748" xml_f="61753" txt_i="43468" txt_f="43473">t0-t3</offsets></sub></td><td><offsets xml_i="61768" xml_f="61788" txt_i="43474" txt_f="43491">Group 2 &lt; Group 4</offsets><break></break><offsets xml_i="61803" xml_f="61823" txt_i="43491" txt_f="43508">Group 4 &gt; Group 6</offsets></td><td><offsets xml_i="61832" xml_f="61868" txt_i="43509" txt_f="43545">Change in questionnaire (continuous)</offsets></td><td><offsets xml_i="61877" xml_f="61882" txt_i="43546" txt_f="43551">ANOVA</offsets><sup><offsets xml_i="61887" xml_f="61888" txt_i="43551" txt_f="43552">a</offsets></sup></td></tr><tr><td><offsets xml_i="61912" xml_f="61925" txt_i="43553" txt_f="43566">5. Change in </offsets><italic><offsets xml_i="61933" xml_f="61967" txt_i="43566" txt_f="43600">6-Minute Walking Test for distance</offsets></italic><offsets xml_i="61976" xml_f="61985" txt_i="43600" txt_f="43609"> (6MWT) Δ</offsets><sub><offsets xml_i="61990" xml_f="61995" txt_i="43609" txt_f="43614">t0-t1</offsets></sub><offsets xml_i="62001" xml_f="62004" txt_i="43614" txt_f="43617">, Δ</offsets><sub><offsets xml_i="62009" xml_f="62014" txt_i="43617" txt_f="43622">t0-t2</offsets></sub><offsets xml_i="62020" xml_f="62023" txt_i="43622" txt_f="43625">, Δ</offsets><sub><offsets xml_i="62028" xml_f="62033" txt_i="43625" txt_f="43630">t0-t3</offsets></sub></td><td><offsets xml_i="62048" xml_f="62068" txt_i="43631" txt_f="43648">Group 2 &lt; Group 4</offsets><break></break><offsets xml_i="62083" xml_f="62103" txt_i="43648" txt_f="43665">Group 4 &gt; Group 6</offsets></td><td><offsets xml_i="62112" xml_f="62148" txt_i="43666" txt_f="43702">Change in meters walked (continuous)</offsets></td><td><offsets xml_i="62157" xml_f="62162" txt_i="43703" txt_f="43708">ANOVA</offsets><sup><offsets xml_i="62167" xml_f="62168" txt_i="43708" txt_f="43709">a</offsets></sup></td></tr><tr><td><offsets xml_i="62192" xml_f="62205" txt_i="43710" txt_f="43723">6. Change in </offsets><italic><offsets xml_i="62213" xml_f="62229" txt_i="43723" txt_f="43739">Stair Climb Test</offsets></italic><offsets xml_i="62238" xml_f="62246" txt_i="43739" txt_f="43747"> (SCT) Δ</offsets><sub><offsets xml_i="62251" xml_f="62256" txt_i="43747" txt_f="43752">t0-t1</offsets></sub><offsets xml_i="62262" xml_f="62265" txt_i="43752" txt_f="43755">, Δ</offsets><sub><offsets xml_i="62270" xml_f="62275" txt_i="43755" txt_f="43760">t0-t2</offsets></sub><offsets xml_i="62281" xml_f="62284" txt_i="43760" txt_f="43763">, Δ</offsets><sub><offsets xml_i="62289" xml_f="62294" txt_i="43763" txt_f="43768">t0-t3</offsets></sub></td><td><offsets xml_i="62309" xml_f="62329" txt_i="43769" txt_f="43786">Group 2 &lt; Group 4</offsets><break></break><offsets xml_i="62344" xml_f="62364" txt_i="43786" txt_f="43803">Group 4 &gt; Group 6</offsets></td><td><offsets xml_i="62373" xml_f="62434" txt_i="43804" txt_f="43865">Change in time used to ascend and descend stairs (continuous)</offsets></td><td><offsets xml_i="62443" xml_f="62448" txt_i="43866" txt_f="43871">ANOVA</offsets><sup><offsets xml_i="62453" xml_f="62454" txt_i="43871" txt_f="43872">a</offsets></sup></td></tr><tr><td><offsets xml_i="62478" xml_f="62491" txt_i="43873" txt_f="43886">7. Change in </offsets><italic><offsets xml_i="62499" xml_f="62516" txt_i="43886" txt_f="43903">current knee pain</offsets></italic><offsets xml_i="62525" xml_f="62553" txt_i="43903" txt_f="43931"> (Numeric Rank Scale, NRS) Δ</offsets><sub><offsets xml_i="62558" xml_f="62563" txt_i="43931" txt_f="43936">t0-t1</offsets></sub><offsets xml_i="62569" xml_f="62572" txt_i="43936" txt_f="43939">, Δ</offsets><sub><offsets xml_i="62577" xml_f="62582" txt_i="43939" txt_f="43944">t0-t2</offsets></sub><offsets xml_i="62588" xml_f="62591" txt_i="43944" txt_f="43947">, Δ</offsets><sub><offsets xml_i="62596" xml_f="62601" txt_i="43947" txt_f="43952">t0-t3</offsets></sub></td><td><offsets xml_i="62616" xml_f="62636" txt_i="43953" txt_f="43970">Group 2 &lt; Group 4</offsets><break></break><offsets xml_i="62651" xml_f="62671" txt_i="43970" txt_f="43987">Group 4 &gt; Group 6</offsets></td><td><offsets xml_i="62680" xml_f="62711" txt_i="43988" txt_f="44019">Change in NRS 0–10 (continuous)</offsets></td><td><offsets xml_i="62720" xml_f="62725" txt_i="44020" txt_f="44025">ANOVA</offsets><sup><offsets xml_i="62730" xml_f="62731" txt_i="44025" txt_f="44026">a</offsets></sup></td></tr><tr><td><offsets xml_i="62755" xml_f="62768" txt_i="44027" txt_f="44040">8. Change in </offsets><italic><offsets xml_i="62776" xml_f="62806" txt_i="44040" txt_f="44070">knee pain during the last week</offsets></italic><offsets xml_i="62815" xml_f="62843" txt_i="44070" txt_f="44098"> (Numeric Rank Scale, NRS) Δ</offsets><sub><offsets xml_i="62848" xml_f="62853" txt_i="44098" txt_f="44103">t0-t1</offsets></sub><offsets xml_i="62859" xml_f="62862" txt_i="44103" txt_f="44106">, Δ</offsets><sub><offsets xml_i="62867" xml_f="62872" txt_i="44106" txt_f="44111">t0-t3</offsets></sub></td><td><break></break><offsets xml_i="62902" xml_f="62922" txt_i="44112" txt_f="44129">Group 4 &gt; Group 6</offsets></td><td><offsets xml_i="62931" xml_f="62962" txt_i="44130" txt_f="44161">Change in NRS 0–10 (continuous)</offsets></td><td><offsets xml_i="62971" xml_f="62976" txt_i="44162" txt_f="44167">ANOVA</offsets><sup><offsets xml_i="62981" xml_f="62982" txt_i="44167" txt_f="44168">a</offsets></sup></td></tr><tr><td><offsets xml_i="63006" xml_f="63024" txt_i="44169" txt_f="44187">9 Distribution in </offsets><italic><offsets xml_i="63032" xml_f="63048" txt_i="44187" txt_f="44203">need for surgery</offsets></italic></td><td><offsets xml_i="63066" xml_f="63086" txt_i="44204" txt_f="44221">Group 2 &lt; Group 4</offsets><break></break><offsets xml_i="63101" xml_f="63121" txt_i="44221" txt_f="44238">Group 4 &gt; Group 6</offsets></td><td><offsets xml_i="63130" xml_f="63149" txt_i="44239" txt_f="44258">Yes, don’t know, no</offsets></td><td><offsets xml_i="63158" xml_f="63176" txt_i="44259" txt_f="44277">Summary statistics</offsets></td></tr><tr><td colspan="4"><offsets xml_i="63206" xml_f="63221" txt_i="44278" txt_f="44293"> Other outcomes</offsets></td></tr><tr><td><offsets xml_i="63239" xml_f="63257" txt_i="44294" txt_f="44312">10. Difference in </offsets><italic><offsets xml_i="63265" xml_f="63290" txt_i="44312" txt_f="44337">adherence to intervention</offsets></italic><offsets xml_i="63299" xml_f="63314" txt_i="44337" txt_f="44352"> between groups</offsets></td><td><offsets xml_i="63323" xml_f="63343" txt_i="44353" txt_f="44370">Group 2 &gt; Group 4</offsets><break></break><offsets xml_i="63358" xml_f="63378" txt_i="44370" txt_f="44387">Group 4 &gt; Group 6</offsets><break></break><offsets xml_i="63393" xml_f="63413" txt_i="44387" txt_f="44404">Group 2 &gt; Group 6</offsets><break></break><offsets xml_i="63428" xml_f="63583" txt_i="44404" txt_f="44559">We hypothesize differences between groups in adherence (%) to the training intervention (i.e., higher number of sessions per week, the lower adherence (%))</offsets></td><td><offsets xml_i="63592" xml_f="63652" txt_i="44560" txt_f="44620">Number of sessions, sets, repetitions and time-under-tension</offsets></td><td><offsets xml_i="63661" xml_f="63666" txt_i="44621" txt_f="44626">ANOVA</offsets><sup><offsets xml_i="63671" xml_f="63672" txt_i="44626" txt_f="44627">a</offsets></sup></td></tr></tbody></table><table-wrap-foot><p><sup><offsets xml_i="63729" xml_f="63730" txt_i="44628" txt_f="44629">a</offsets></sup><offsets xml_i="63736" xml_f="63824" txt_i="44629" txt_f="44717">If data are not normally distributed the non-parametric Kruskal-Wallis test will be used</offsets></p><p><offsets xml_i="63831" xml_f="63860" txt_i="44718" txt_f="44747">Analysis of variance: (ANOVA)</offsets></p></table-wrap-foot></table-wrap></p></sec><sec id="Sec30"><title><offsets xml_i="63928" xml_f="63944" txt_i="44750" txt_f="44766">Primary analysis</offsets></title><p id="Par87"><offsets xml_i="63966" xml_f="64075" txt_i="44767" txt_f="44876">The primary analysis will be between-group contrasts for the primary outcome at the primary endpoint. Figure </offsets><xref rid="Fig6" ref-type="fig"><offsets xml_i="64107" xml_f="64108" txt_i="44876" txt_f="44877">6</offsets></xref><offsets xml_i="64115" xml_f="64248" txt_i="44877" txt_f="45010"> illustrates a hypothetical presentation of changes in isometric knee-extensor strength at the primary endpoint for the three groups.</offsets><fig id="Fig6"><label><offsets xml_i="64270" xml_f="64276" txt_i="45010" txt_f="45016">Fig. 6</offsets></label><caption><p><offsets xml_i="64296" xml_f="64455" txt_i="45016" txt_f="45175">A hypothetical presentation of group changes from baseline to the primary endpoint (after 12 weeks of exercise) for the primary outcome, knee-extensor strength</offsets></p></caption><graphic xlink:href="13063_2017_2366_Fig6_HTML" id="MO6"></graphic></fig></p></sec><sec id="Sec31"><title><offsets xml_i="64575" xml_f="64593" txt_i="45178" txt_f="45196">Secondary analyses</offsets></title><p id="Par88"><offsets xml_i="64615" xml_f="64744" txt_i="45197" txt_f="45326">The secondary analyses will be between-group contrasts for the secondary outcomes at the primary and secondary endpoints. Figure </offsets><xref rid="Fig7" ref-type="fig"><offsets xml_i="64776" xml_f="64777" txt_i="45326" txt_f="45327">7</offsets></xref><offsets xml_i="64784" xml_f="64923" txt_i="45327" txt_f="45466"> illustrates a hypothetical presentation of changes in isometric knee-extensor strength for the three groups during the whole trial period.</offsets><fig id="Fig7"><label><offsets xml_i="64945" xml_f="64951" txt_i="45466" txt_f="45472">Fig. 7</offsets></label><caption><p><offsets xml_i="64971" xml_f="65122" txt_i="45472" txt_f="45623">A hypothetical presentation of group changes in knee-extensor strength over the whole trial period. NB, control data are from the academic literature [</offsets><xref ref-type="bibr" rid="CR11"><offsets xml_i="65155" xml_f="65157" txt_i="45623" txt_f="45625">11</offsets></xref><offsets xml_i="65164" xml_f="65243" txt_i="45625" txt_f="45704">] and so are the healthy, age-matched, control data (age 66.8 years (6.5 SD)) [</offsets><xref ref-type="bibr" rid="CR7"><offsets xml_i="65275" xml_f="65276" txt_i="45704" txt_f="45705">7</offsets></xref><offsets xml_i="65283" xml_f="65284" txt_i="45705" txt_f="45706">]</offsets></p></caption><graphic xlink:href="13063_2017_2366_Fig7_HTML" id="MO7"></graphic></fig></p><p id="Par89"><offsets xml_i="65389" xml_f="65589" txt_i="45708" txt_f="45908">For all outcomes (primary and secondary), mean scores with corresponding standard deviations (SD), and between-group contrasts (change scores) with corresponding 95% confidence intervals (95% CI) and </offsets><italic><offsets xml_i="65597" xml_f="65598" txt_i="45908" txt_f="45909">p</offsets></italic><offsets xml_i="65607" xml_f="65651" txt_i="45909" txt_f="45953"> value, will be reported at each endpoint (t</offsets><sub><offsets xml_i="65656" xml_f="65657" txt_i="45953" txt_f="45954">0</offsets></sub><offsets xml_i="65663" xml_f="65666" txt_i="45954" txt_f="45957">, t</offsets><sub><offsets xml_i="65671" xml_f="65672" txt_i="45957" txt_f="45958">1</offsets></sub><offsets xml_i="65678" xml_f="65681" txt_i="45958" txt_f="45961">, t</offsets><sub><offsets xml_i="65686" xml_f="65687" txt_i="45961" txt_f="45962">2</offsets></sub><offsets xml_i="65693" xml_f="65699" txt_i="45962" txt_f="45968"> and t</offsets><sub><offsets xml_i="65704" xml_f="65705" txt_i="45968" txt_f="45969">3</offsets></sub><offsets xml_i="65711" xml_f="65755" txt_i="45969" txt_f="46013">) for each group (groups 2, 4 and 6) (Table </offsets><xref rid="Tab4" ref-type="table"><offsets xml_i="65789" xml_f="65790" txt_i="46013" txt_f="46014">4</offsets></xref><offsets xml_i="65797" xml_f="65799" txt_i="46014" txt_f="46016">).</offsets><table-wrap id="Tab4"><label><offsets xml_i="65828" xml_f="65835" txt_i="46016" txt_f="46023">Table 4</offsets></label><caption><p><offsets xml_i="65855" xml_f="65898" txt_i="46023" txt_f="46066">Outcomes for primary and secondary analyses</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><th></th><th colspan="3"><offsets xml_i="65985" xml_f="65986" txt_i="46067" txt_f="46068">t</offsets><sub><offsets xml_i="65991" xml_f="65992" txt_i="46068" txt_f="46069">0</offsets></sub><break></break><offsets xml_i="66013" xml_f="66021" txt_i="46069" txt_f="46077">Baseline</offsets></th><th colspan="3"><offsets xml_i="66042" xml_f="66043" txt_i="46077" txt_f="46078">t</offsets><sub><offsets xml_i="66048" xml_f="66049" txt_i="46078" txt_f="46079">1</offsets></sub><break></break><offsets xml_i="66070" xml_f="66092" txt_i="46079" txt_f="46101">After 12-week exercise</offsets></th><th colspan="3"><offsets xml_i="66113" xml_f="66114" txt_i="46101" txt_f="46102">t</offsets><sub><offsets xml_i="66119" xml_f="66120" txt_i="46102" txt_f="46103">2</offsets></sub><break></break><offsets xml_i="66141" xml_f="66176" txt_i="46103" txt_f="46138">After surgery at hospital discharge</offsets></th><th colspan="3"><offsets xml_i="66197" xml_f="66198" txt_i="46138" txt_f="46139">t</offsets><sub><offsets xml_i="66203" xml_f="66204" txt_i="46139" txt_f="46140">3</offsets></sub><break></break><offsets xml_i="66225" xml_f="66247" txt_i="46140" txt_f="46162">3 months after surgery</offsets></th><th><offsets xml_i="66256" xml_f="66304" txt_i="46162" txt_f="46210">Between-group contrasts (change scores) 95% CI (</offsets><italic><offsets xml_i="66312" xml_f="66313" txt_i="46210" txt_f="46211">p</offsets></italic><offsets xml_i="66322" xml_f="66323" txt_i="46211" txt_f="46212">)</offsets></th></tr><tr><th><offsets xml_i="66341" xml_f="66349" txt_i="46212" txt_f="46220">Mean, SD</offsets></th><th><offsets xml_i="66358" xml_f="66363" txt_i="46220" txt_f="46225">Gp. 2</offsets></th><th><offsets xml_i="66372" xml_f="66377" txt_i="46225" txt_f="46230">Gp. 4</offsets></th><th><offsets xml_i="66386" xml_f="66391" txt_i="46230" txt_f="46235">Gp. 6</offsets></th><th><offsets xml_i="66400" xml_f="66405" txt_i="46235" txt_f="46240">Gp. 2</offsets></th><th><offsets xml_i="66414" xml_f="66419" txt_i="46240" txt_f="46245">Gp. 4</offsets></th><th><offsets xml_i="66428" xml_f="66433" txt_i="46245" txt_f="46250">Gp. 6</offsets></th><th><offsets xml_i="66442" xml_f="66447" txt_i="46250" txt_f="46255">Gp. 2</offsets></th><th><offsets xml_i="66456" xml_f="66461" txt_i="46255" txt_f="46260">Gp. 4</offsets></th><th><offsets xml_i="66470" xml_f="66475" txt_i="46260" txt_f="46265">Gp. 6</offsets></th><th><offsets xml_i="66484" xml_f="66489" txt_i="46265" txt_f="46270">Gp. 2</offsets></th><th><offsets xml_i="66498" xml_f="66503" txt_i="46270" txt_f="46275">Gp. 4</offsets></th><th><offsets xml_i="66512" xml_f="66517" txt_i="46275" txt_f="46280">Gp. 6</offsets></th><th></th></tr></thead><tbody><tr><td><offsets xml_i="66559" xml_f="66599" txt_i="46280" txt_f="46320">Isometric knee-extensor strength (Nm/kg)</offsets></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td><offsets xml_i="66716" xml_f="66734" txt_i="46333" txt_f="46351">Primary analysis Δ</offsets><sub><offsets xml_i="66739" xml_f="66744" txt_i="46351" txt_f="46356">t0-t1</offsets></sub><break></break><offsets xml_i="66765" xml_f="66785" txt_i="46356" txt_f="46376">Secondary analysis Δ</offsets><sub><offsets xml_i="66790" xml_f="66796" txt_i="46376" txt_f="46382">t0- t2</offsets></sub><offsets xml_i="66802" xml_f="66804" txt_i="46382" txt_f="46384">, </offsets><sub><offsets xml_i="66809" xml_f="66814" txt_i="46384" txt_f="46389">t0-t3</offsets></sub></td></tr><tr><td><offsets xml_i="66838" xml_f="66879" txt_i="46390" txt_f="46431">6-Minute Walking Test for distance (6MWT)</offsets></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td><offsets xml_i="66996" xml_f="67016" txt_i="46444" txt_f="46464">Secondary analysis Δ</offsets><sub><offsets xml_i="67021" xml_f="67026" txt_i="46464" txt_f="46469">t0-t1</offsets></sub><offsets xml_i="67032" xml_f="67035" txt_i="46469" txt_f="46472">, Δ</offsets><sub><offsets xml_i="67040" xml_f="67045" txt_i="46472" txt_f="46477">t0-t2</offsets></sub><offsets xml_i="67051" xml_f="67054" txt_i="46477" txt_f="46480">, Δ</offsets><sub><offsets xml_i="67059" xml_f="67064" txt_i="46480" txt_f="46485">t0-t3</offsets></sub></td></tr><tr><td><offsets xml_i="67088" xml_f="67110" txt_i="46486" txt_f="46508">Stair Climb Test (SCT)</offsets></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td><offsets xml_i="67227" xml_f="67247" txt_i="46521" txt_f="46541">Secondary analysis Δ</offsets><sub><offsets xml_i="67252" xml_f="67257" txt_i="46541" txt_f="46546">t0-t1</offsets></sub><offsets xml_i="67263" xml_f="67266" txt_i="46546" txt_f="46549">, Δ</offsets><sub><offsets xml_i="67271" xml_f="67276" txt_i="46549" txt_f="46554">t0-t2</offsets></sub><offsets xml_i="67282" xml_f="67285" txt_i="46554" txt_f="46557">, Δ</offsets><sub><offsets xml_i="67290" xml_f="67295" txt_i="46557" txt_f="46562">t0-t3</offsets></sub></td></tr><tr><td><offsets xml_i="67319" xml_f="67359" txt_i="46563" txt_f="46603">Knee Osteoarthritis Outcome Score (KOOS)</offsets></td><td></td><td></td><td></td><td></td><td></td><td></td><td><offsets xml_i="67422" xml_f="67424" txt_i="46610" txt_f="46612">Na</offsets></td><td><offsets xml_i="67433" xml_f="67435" txt_i="46613" txt_f="46615">Na</offsets></td><td><offsets xml_i="67444" xml_f="67446" txt_i="46616" txt_f="46618">Na</offsets></td><td></td><td></td><td></td><td><offsets xml_i="67482" xml_f="67502" txt_i="46622" txt_f="46642">Secondary analysis Δ</offsets><sub><offsets xml_i="67507" xml_f="67512" txt_i="46642" txt_f="46647">t0-t1</offsets></sub><offsets xml_i="67518" xml_f="67521" txt_i="46647" txt_f="46650">, Δ</offsets><sub><offsets xml_i="67526" xml_f="67531" txt_i="46650" txt_f="46655">t0-t3</offsets></sub></td></tr><tr><td><offsets xml_i="67555" xml_f="67578" txt_i="46656" txt_f="46679">Oxford Knee Score (OKS)</offsets></td><td></td><td></td><td></td><td></td><td></td><td></td><td><offsets xml_i="67641" xml_f="67643" txt_i="46686" txt_f="46688">Na</offsets></td><td><offsets xml_i="67652" xml_f="67654" txt_i="46689" txt_f="46691">Na</offsets></td><td><offsets xml_i="67663" xml_f="67665" txt_i="46692" txt_f="46694">Na</offsets></td><td></td><td></td><td></td><td><offsets xml_i="67701" xml_f="67721" txt_i="46698" txt_f="46718">Secondary analysis Δ</offsets><sub><offsets xml_i="67726" xml_f="67731" txt_i="46718" txt_f="46723">t0-t1</offsets></sub><offsets xml_i="67737" xml_f="67740" txt_i="46723" txt_f="46726">, Δ</offsets><sub><offsets xml_i="67745" xml_f="67750" txt_i="46726" txt_f="46731">t0-t3</offsets></sub></td></tr><tr><td><offsets xml_i="67774" xml_f="67825" txt_i="46732" txt_f="46783">Current knee pain (Numeric Rating Scale (NRS) 0–10)</offsets></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td><offsets xml_i="67942" xml_f="67962" txt_i="46796" txt_f="46816">Secondary analysis Δ</offsets><sub><offsets xml_i="67967" xml_f="67972" txt_i="46816" txt_f="46821">t0-t1</offsets></sub><offsets xml_i="67978" xml_f="67981" txt_i="46821" txt_f="46824">, Δ</offsets><sub><offsets xml_i="67986" xml_f="67991" txt_i="46824" txt_f="46829">t0-t2</offsets></sub><offsets xml_i="67997" xml_f="68000" txt_i="46829" txt_f="46832">, Δ</offsets><sub><offsets xml_i="68005" xml_f="68010" txt_i="46832" txt_f="46837">t0-t3</offsets></sub></td></tr><tr><td><offsets xml_i="68034" xml_f="68075" txt_i="46838" txt_f="46879">Knee pain during the last week (NRS 0–10)</offsets></td><td></td><td></td><td></td><td></td><td></td><td></td><td><offsets xml_i="68138" xml_f="68140" txt_i="46886" txt_f="46888">Na</offsets></td><td><offsets xml_i="68149" xml_f="68151" txt_i="46889" txt_f="46891">Na</offsets></td><td><offsets xml_i="68160" xml_f="68162" txt_i="46892" txt_f="46894">Na</offsets></td><td></td><td></td><td></td><td><offsets xml_i="68198" xml_f="68218" txt_i="46898" txt_f="46918">Secondary analysis Δ</offsets><sub><offsets xml_i="68223" xml_f="68228" txt_i="46918" txt_f="46923">t0-t1</offsets></sub><offsets xml_i="68234" xml_f="68237" txt_i="46923" txt_f="46926">, Δ</offsets><sub><offsets xml_i="68242" xml_f="68247" txt_i="46926" txt_f="46931">t0-t3</offsets></sub></td></tr><tr><td><offsets xml_i="68271" xml_f="68311" txt_i="46932" txt_f="46972">Need for surgery now (yes/don’t know/no)</offsets></td><td><offsets xml_i="68320" xml_f="68322" txt_i="46973" txt_f="46975">Na</offsets></td><td><offsets xml_i="68331" xml_f="68333" txt_i="46976" txt_f="46978">Na</offsets></td><td><offsets xml_i="68342" xml_f="68344" txt_i="46979" txt_f="46981">Na</offsets></td><td></td><td></td><td></td><td><offsets xml_i="68380" xml_f="68382" txt_i="46985" txt_f="46987">Na</offsets></td><td><offsets xml_i="68391" xml_f="68393" txt_i="46988" txt_f="46990">Na</offsets></td><td><offsets xml_i="68402" xml_f="68404" txt_i="46991" txt_f="46993">Na</offsets></td><td><offsets xml_i="68413" xml_f="68415" txt_i="46994" txt_f="46996">Na</offsets></td><td><offsets xml_i="68424" xml_f="68426" txt_i="46997" txt_f="46999">Na</offsets></td><td><offsets xml_i="68435" xml_f="68437" txt_i="47000" txt_f="47002">Na</offsets></td><td><offsets xml_i="68446" xml_f="68464" txt_i="47003" txt_f="47021">Secondary analysis</offsets></td></tr><tr><td><offsets xml_i="68482" xml_f="68500" txt_i="47022" txt_f="47040">Exercise adherence</offsets></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td><offsets xml_i="68635" xml_f="68687" txt_i="47054" txt_f="47106"> • No. sessions (prescribed, completed, % completed)</offsets></td><td><offsets xml_i="68696" xml_f="68698" txt_i="47107" txt_f="47109">Na</offsets></td><td><offsets xml_i="68707" xml_f="68709" txt_i="47110" txt_f="47112">Na</offsets></td><td><offsets xml_i="68718" xml_f="68720" txt_i="47113" txt_f="47115">Na</offsets></td><td></td><td></td><td></td><td></td><td></td><td></td><td><offsets xml_i="68783" xml_f="68785" txt_i="47122" txt_f="47124">Na</offsets></td><td><offsets xml_i="68794" xml_f="68796" txt_i="47125" txt_f="47127">Na</offsets></td><td><offsets xml_i="68805" xml_f="68807" txt_i="47128" txt_f="47130">Na</offsets></td><td><offsets xml_i="68816" xml_f="68834" txt_i="47131" txt_f="47149">Secondary analysis</offsets></td></tr><tr><td><offsets xml_i="68852" xml_f="68933" txt_i="47150" txt_f="47231"> • Seconds of total time-under-tension (TUT) (prescribed, completed, % completed)</offsets></td><td><offsets xml_i="68942" xml_f="68944" txt_i="47232" txt_f="47234">Na</offsets></td><td><offsets xml_i="68953" xml_f="68955" txt_i="47235" txt_f="47237">Na</offsets></td><td><offsets xml_i="68964" xml_f="68966" txt_i="47238" txt_f="47240">Na</offsets></td><td></td><td></td><td></td><td></td><td></td><td></td><td><offsets xml_i="69029" xml_f="69031" txt_i="47247" txt_f="47249">Na</offsets></td><td><offsets xml_i="69040" xml_f="69042" txt_i="47250" txt_f="47252">Na</offsets></td><td><offsets xml_i="69051" xml_f="69053" txt_i="47253" txt_f="47255">Na</offsets></td><td><offsets xml_i="69062" xml_f="69080" txt_i="47256" txt_f="47274">Secondary analysis</offsets></td></tr><tr><td><offsets xml_i="69098" xml_f="69112" txt_i="47275" txt_f="47289">Adverse events</offsets></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td><offsets xml_i="69229" xml_f="69247" txt_i="47302" txt_f="47320">Secondary analysis</offsets></td></tr></tbody></table></table-wrap></p><p id="Par90"><offsets xml_i="69304" xml_f="69461" txt_i="47322" txt_f="47479">The patients who choose not to be operated with TKA after the exercise period will be followed with annual outcome assessments as part of a small case study.</offsets></p><p id="Par91"><offsets xml_i="69479" xml_f="69557" txt_i="47480" txt_f="47558">Descriptive statistics for the trial population will be presented as in Table </offsets><xref rid="Tab5" ref-type="table"><offsets xml_i="69591" xml_f="69592" txt_i="47558" txt_f="47559">5</offsets></xref><offsets xml_i="69599" xml_f="69600" txt_i="47559" txt_f="47560">.</offsets><table-wrap id="Tab5"><label><offsets xml_i="69629" xml_f="69636" txt_i="47560" txt_f="47567">Table 5</offsets></label><caption><p><offsets xml_i="69656" xml_f="69678" txt_i="47567" txt_f="47589">Descriptive statistics</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><th></th><th><offsets xml_i="69753" xml_f="69758" txt_i="47590" txt_f="47595">Gp. 2</offsets></th><th><offsets xml_i="69767" xml_f="69772" txt_i="47595" txt_f="47600">Gp. 4</offsets></th><th><offsets xml_i="69781" xml_f="69786" txt_i="47600" txt_f="47605">Gp. 6</offsets></th><th><offsets xml_i="69795" xml_f="69807" txt_i="47605" txt_f="47617">All patients</offsets></th></tr></thead><tbody><tr><td><offsets xml_i="69840" xml_f="69851" txt_i="47617" txt_f="47628">Age (years)</offsets></td><td></td><td></td><td></td><td></td></tr><tr><td><offsets xml_i="69905" xml_f="69916" txt_i="47633" txt_f="47644">Height (cm)</offsets></td><td></td><td></td><td></td><td></td></tr><tr><td><offsets xml_i="69970" xml_f="69981" txt_i="47649" txt_f="47660">Weight (kg)</offsets></td><td></td><td></td><td></td><td></td></tr><tr><td><offsets xml_i="70035" xml_f="70047" txt_i="47665" txt_f="47677">Gender (m/f)</offsets></td><td></td><td></td><td></td><td></td></tr><tr><td><offsets xml_i="70101" xml_f="70117" txt_i="47682" txt_f="47698">Index knee (r/l)</offsets></td><td></td><td></td><td></td><td></td></tr><tr><td><offsets xml_i="70171" xml_f="70210" txt_i="47703" txt_f="47742">Kellgren-Lawrence classification (I–IV)</offsets></td><td></td><td></td><td></td><td></td></tr></tbody></table></table-wrap></p></sec><sec id="Sec32"><title><offsets xml_i="70318" xml_f="70340" txt_i="47749" txt_f="47771">Supplementary analyses</offsets></title><p id="Par92"><offsets xml_i="70362" xml_f="70951" txt_i="47772" txt_f="48361">The supplementary analyses will be simple regression models in which the three exercise dosage groups will be pooled, allowing us to utilize the full dataset; that is, the exercise dosage recorded by the sensors will be used in the analysis, not the prescribed exercise dosage. The dependent variables will be the change in primary and secondary outcomes from baseline to the primary endpoint and to the secondary endpoints. The independent variable will be exercise dosage, quantified in two ways: (1) as total TUT and (2) as number of completed exercise sessions for each patient (Table </offsets><xref rid="Tab6" ref-type="table"><offsets xml_i="70985" xml_f="70986" txt_i="48361" txt_f="48362">6</offsets></xref><offsets xml_i="70993" xml_f="71003" txt_i="48362" txt_f="48372">). Figure </offsets><xref rid="Fig8" ref-type="fig"><offsets xml_i="71035" xml_f="71036" txt_i="48372" txt_f="48373">8</offsets></xref><offsets xml_i="71043" xml_f="71187" txt_i="48373" txt_f="48517"> illustrates a hypothetical simple regression model with the change in isometric knee-extensor strength (Nm/kg) at the primary endpoint and TUT.</offsets><table-wrap id="Tab6"><label><offsets xml_i="71216" xml_f="71223" txt_i="48517" txt_f="48524">Table 6</offsets></label><caption><p><offsets xml_i="71243" xml_f="71287" txt_i="48524" txt_f="48568">Regression models for supplementary analysis</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="3"><offsets xml_i="71365" xml_f="71425" txt_i="48569" txt_f="48629">Supplementary analyses (primary outcome at primary endpoint)</offsets></th></tr><tr><th></th><th><offsets xml_i="71452" xml_f="71474" txt_i="48629" txt_f="48651">Dependent variable (y)</offsets></th><th><offsets xml_i="71483" xml_f="71507" txt_i="48651" txt_f="48675">Independent variable (x)</offsets></th></tr></thead><tbody><tr><td><offsets xml_i="71540" xml_f="71563" txt_i="48675" txt_f="48698">Linear regression model</offsets></td><td><offsets xml_i="71572" xml_f="71582" txt_i="48699" txt_f="48709">Change in </offsets><italic><offsets xml_i="71590" xml_f="71622" txt_i="48709" txt_f="48741">isometric knee-extensor strength</offsets></italic><offsets xml_i="71631" xml_f="71633" txt_i="48741" txt_f="48743"> Δ</offsets><sub><offsets xml_i="71638" xml_f="71643" txt_i="48743" txt_f="48748">t0-t1</offsets></sub></td><td><offsets xml_i="71658" xml_f="71676" txt_i="48749" txt_f="48767">Exercise adherence</offsets><break></break><offsets xml_i="71691" xml_f="71733" txt_i="48767" txt_f="48809"> Seconds of total time-under-tension (TUT)</offsets><break></break><offsets xml_i="71748" xml_f="71786" txt_i="48809" txt_f="48847"> Number of completed exercise sessions</offsets></td></tr><tr><td colspan="3"><offsets xml_i="71816" xml_f="71894" txt_i="48848" txt_f="48926">Supplementary analyses (secondary outcomes at primary and secondary endpoints)</offsets></td></tr><tr><td rowspan="9"><offsets xml_i="71924" xml_f="71948" txt_i="48927" txt_f="48951">Linear regression models</offsets></td><td><offsets xml_i="71957" xml_f="71967" txt_i="48952" txt_f="48962">Change in </offsets><italic><offsets xml_i="71975" xml_f="72007" txt_i="48962" txt_f="48994">isometric knee-extensor strength</offsets></italic><offsets xml_i="72016" xml_f="72018" txt_i="48994" txt_f="48996"> Δ</offsets><sub><offsets xml_i="72023" xml_f="72028" txt_i="48996" txt_f="49001">t0-t2</offsets></sub><offsets xml_i="72034" xml_f="72037" txt_i="49001" txt_f="49004">, Δ</offsets><sub><offsets xml_i="72042" xml_f="72047" txt_i="49004" txt_f="49009">t0-t3</offsets></sub></td><td rowspan="9"><offsets xml_i="72074" xml_f="72092" txt_i="49010" txt_f="49028">Exercise adherence</offsets><break></break><offsets xml_i="72107" xml_f="72149" txt_i="49028" txt_f="49070"> Seconds of total time-under-tension (TUT)</offsets><break></break><offsets xml_i="72164" xml_f="72202" txt_i="49070" txt_f="49108"> Number of completed exercise sessions</offsets></td></tr><tr><td><offsets xml_i="72220" xml_f="72230" txt_i="49109" txt_f="49119">Change in </offsets><italic><offsets xml_i="72238" xml_f="72269" txt_i="49119" txt_f="49150">6-minute walk test for distance</offsets></italic><offsets xml_i="72278" xml_f="72287" txt_i="49150" txt_f="49159"> (6MWT) Δ</offsets><sub><offsets xml_i="72292" xml_f="72311" txt_i="49159" txt_f="49178">t0-t1, t0-t2, t0-t3</offsets></sub></td></tr><tr><td><offsets xml_i="72335" xml_f="72345" txt_i="49179" txt_f="49189">Change in </offsets><italic><offsets xml_i="72353" xml_f="72369" txt_i="49189" txt_f="49205">stair climb test</offsets></italic><offsets xml_i="72378" xml_f="72386" txt_i="49205" txt_f="49213"> (SCT) Δ</offsets><sub><offsets xml_i="72391" xml_f="72410" txt_i="49213" txt_f="49232">t0-t1, t0-t2, t0-t3</offsets></sub></td></tr><tr><td><offsets xml_i="72434" xml_f="72444" txt_i="49233" txt_f="49243">Change in </offsets><italic><offsets xml_i="72452" xml_f="72485" txt_i="49243" txt_f="49276">Knee Osteoarthritis Outcome Score</offsets></italic><offsets xml_i="72494" xml_f="72514" txt_i="49276" txt_f="49296"> (KOOS) subscales Δ </offsets><sub><offsets xml_i="72519" xml_f="72531" txt_i="49296" txt_f="49308">t0-t1, t0-t3</offsets></sub></td></tr><tr><td><offsets xml_i="72555" xml_f="72565" txt_i="49309" txt_f="49319">Change in </offsets><italic><offsets xml_i="72573" xml_f="72590" txt_i="49319" txt_f="49336">Oxford Knee Score</offsets></italic><offsets xml_i="72599" xml_f="72608" txt_i="49336" txt_f="49345"> (OKS) Δ </offsets><sub><offsets xml_i="72613" xml_f="72625" txt_i="49345" txt_f="49357">t0-t1, t0-t3</offsets></sub></td></tr><tr><td><offsets xml_i="72649" xml_f="72659" txt_i="49358" txt_f="49368">Change in </offsets><italic><offsets xml_i="72667" xml_f="72684" txt_i="49368" txt_f="49385">current knee pain</offsets></italic><offsets xml_i="72693" xml_f="72724" txt_i="49385" txt_f="49416"> (Numeric Rating Scale, NRS) Δ </offsets><sub><offsets xml_i="72729" xml_f="72748" txt_i="49416" txt_f="49435">t0-t1, t0-t2, t0-t3</offsets></sub></td></tr><tr><td><offsets xml_i="72772" xml_f="72782" txt_i="49436" txt_f="49446">Change in </offsets><italic><offsets xml_i="72790" xml_f="72820" txt_i="49446" txt_f="49476">knee pain during the last week</offsets></italic><offsets xml_i="72829" xml_f="72860" txt_i="49476" txt_f="49507"> (Numeric Rating Scale, NRS) Δ </offsets><sub><offsets xml_i="72865" xml_f="72877" txt_i="49507" txt_f="49519">t0-t1, t0-t3</offsets></sub></td></tr><tr><td><offsets xml_i="72901" xml_f="72937" txt_i="49520" txt_f="49556">Need for surgery (yes/don’t know/no)</offsets></td></tr><tr><td><offsets xml_i="72955" xml_f="72968" txt_i="49557" txt_f="49570">Averse events</offsets></td></tr></tbody></table></table-wrap><fig id="Fig8"><label><offsets xml_i="73029" xml_f="73035" txt_i="49571" txt_f="49577">Fig. 8</offsets></label><caption><p><offsets xml_i="73055" xml_f="73206" txt_i="49577" txt_f="49728">A hypothetical simple regression model with the change in isometric knee-extensor strength (Nm/kg) at the primary endpoint and time-under-tension (TUT)</offsets></p></caption><graphic xlink:href="13063_2017_2366_Fig8_HTML" id="MO8"></graphic></fig><fig id="Fig9"><label><offsets xml_i="73315" xml_f="73321" txt_i="49729" txt_f="49735">Fig. 9</offsets></label><caption><p><offsets xml_i="73341" xml_f="73507" txt_i="49735" txt_f="49901">Elastic exercise band fixation to an immoveable object (e.g., an elastic exercise band anchor behind a closed door) and placement around the ankle of the exercise leg</offsets></p></caption><graphic xlink:href="13063_2017_2366_Fig9_HTML" id="MO9"></graphic></fig></p></sec></sec><sec id="Sec33"><title><offsets xml_i="73633" xml_f="73645" txt_i="49905" txt_f="49917">Missing data</offsets></title><p id="Par93"><offsets xml_i="73667" xml_f="73965" txt_i="49918" txt_f="50216">All analyses will follow the intention-to-treat (ITT) principle with a clear registration and reporting of the drop-out rate. All patients will be analyzed as randomized. To create a full analysis dataset for the intention-to-treat analyses, missing data will be imputed using multiple imputations.</offsets></p></sec><sec id="Sec34"><title><offsets xml_i="73998" xml_f="74013" txt_i="50218" txt_f="50233">Data monitoring</offsets></title><p id="Par94"><offsets xml_i="74035" xml_f="74551" txt_i="50234" txt_f="50750">As the intervention(s) provided in the present trial poses little or no risk to the participating patients, no data monitoring committee will be composed. Funding sources of the current trial has no part in the design, conduction or reporting of the trial, thus there is no conflict of interests. As the intervention(s) poses little or no risk to the participating patients no interim analyses will be applied. Stopping guidelines for discontinuing and modifying the exercise has been described previously (see the “</offsets><xref rid="Sec13" ref-type="sec"><offsets xml_i="74584" xml_f="74624" txt_i="50750" txt_f="50790">Criteria for modifying and discontinuing</offsets></xref><offsets xml_i="74631" xml_f="74642" txt_i="50790" txt_f="50801">” section).</offsets></p></sec><sec id="Sec35"><title><offsets xml_i="74675" xml_f="74708" txt_i="50803" txt_f="50836">Access to the final trial dataset</offsets></title><p id="Par95"><offsets xml_i="74730" xml_f="75134" txt_i="50837" txt_f="51241">The principal investigator and principal supervisor will have full access to the dataset as well as all co-authors. A fully patient-anonymized dataset and corresponding statistical analysis code will be made available for the scientific journal reviewing the manuscript and its results within 6 months in line with the recent proposal from the International Committee of Medical Journal Editors (ICMJE) [</offsets><xref ref-type="bibr" rid="CR52"><offsets xml_i="75167" xml_f="75169" txt_i="51241" txt_f="51243">52</offsets></xref><offsets xml_i="75176" xml_f="75178" txt_i="51243" txt_f="51245">].</offsets></p></sec><sec id="Sec36"><title><offsets xml_i="75211" xml_f="75240" txt_i="51247" txt_f="51276">Ancillary and post-trial care</offsets></title><p id="Par96"><offsets xml_i="75262" xml_f="75549" txt_i="51277" txt_f="51564">The current trial is not planned to include patient ancillary care or post-trial care. On completion of the trial, if participants want to continue with the exercises independently they can do so. However, this will not be a part of the trial and will be on the patient’s own initiative.</offsets></p></sec><sec id="Sec37"><title><offsets xml_i="75582" xml_f="75602" txt_i="51566" txt_f="51586">Dissemination policy</offsets></title><p id="Par97"><offsets xml_i="75624" xml_f="76758" txt_i="51587" txt_f="52721">The QUADX-1 trial is planned to be reported in three manuscripts, which will be published in scientific peer-reviewed journals. All manuscripts will refer to the QUADX-1 trial’s Clinical.Trials.gov identifier. The first manuscript will be the trial protocol, the second manuscript will be the primary trial report of the investigated dose-response relationship, and the third manuscript will be a qualitative study investigating enablers and barriers for patient adherence to home-based exercise and physiotherapists’ experience in administering home-based exercise before TKA. The results will also be presented at relevant scientific conferences and symposiums. Trial participants will be informed of the trial via a letter explaining the results in layman’s terms. On request, the data underlying the results presented in the manuscript will be available to reproduce the findings. We intend to make the dataset – containing de-identified individual patient data – publicly available no later than 6 months after publication, consistent with the recent proposal from the International Committee of Medical Journal Editors (ICMJE) [</offsets><xref ref-type="bibr" rid="CR52"><offsets xml_i="76791" xml_f="76793" txt_i="52721" txt_f="52723">52</offsets></xref><offsets xml_i="76800" xml_f="77052" txt_i="52723" txt_f="52975">], if it complies with national regulations, e.g., the Danish Data Protection Agency. Trial data can be requested by contacting the main investigator (RSH) or trial director (TB). Positive as well as negative and inconclusive results will be published.</offsets></p><p id="Par98"><offsets xml_i="77070" xml_f="77268" txt_i="52976" txt_f="53174">All contributors to the study will be offered to co-author the three above manuscripts if they fulfill the International Committee of Medical Journal Editors (ICMJE) recommendations for authorship [</offsets><xref ref-type="bibr" rid="CR52"><offsets xml_i="77301" xml_f="77303" txt_i="53174" txt_f="53176">52</offsets></xref><offsets xml_i="77310" xml_f="77350" txt_i="53176" txt_f="53216">]. No professional writers will be used.</offsets></p></sec></sec><sec id="Sec38"><title><offsets xml_i="77389" xml_f="77399" txt_i="53219" txt_f="53229">Discussion</offsets></title><p id="Par99"><offsets xml_i="77421" xml_f="77644" txt_i="53230" txt_f="53453">In 2011, approximately 60,000 patients were registered in the Danish health care system with symptoms of knee OA and the annual incidence of knee OA has increased from 35.8 in 1997 to 155.2 in 2010 per 100,000 inhabitants [</offsets><xref ref-type="bibr" rid="CR3"><offsets xml_i="77676" xml_f="77677" txt_i="53453" txt_f="53454">3</offsets></xref><offsets xml_i="77684" xml_f="77833" txt_i="53454" txt_f="53603">]. Consequently, this population is very large and growing, which stresses the importance of optimizing the treatment offered to these patients. The </offsets><italic><offsets xml_i="77841" xml_f="77854" txt_i="53603" txt_f="53616">QUADX-1 trial</offsets></italic><offsets xml_i="77863" xml_f="78122" txt_i="53616" txt_f="53875"> will add knowledge relating to which knee-extensor strength exercise dosage is most effective in increasing knee-extensor strength and whether a single, home-based (unsupervised) knee-extensor strength exercise is feasible in patients with end-stage knee OA.</offsets></p><p id="Par100"><offsets xml_i="78141" xml_f="78253" txt_i="53876" txt_f="53988">The minimal treatment approach (single exercise) has been chosen as it is a pragmatic and time-saving solution [</offsets><xref ref-type="bibr" rid="CR46"><offsets xml_i="78286" xml_f="78288" txt_i="53988" txt_f="53990">46</offsets></xref><offsets xml_i="78295" xml_f="78755" txt_i="53990" txt_f="54450">]. Further, the rationale for investigating a home-based, single knee-extensor strength exercise is that it could improve exercise adherence as it is simple (minimal intellectual effort), does not take a long time (requires less surplus energy) and is likely to inflict less pain (less stress imposed on the knee joint). An exercise targeting the knee-extensor muscle is chosen as it is the single most important muscle for function in the knee OA population [</offsets><xref ref-type="bibr" rid="CR9"><offsets xml_i="78787" xml_f="78788" txt_i="54450" txt_f="54451">9</offsets></xref><offsets xml_i="78795" xml_f="78797" txt_i="54451" txt_f="54453">, </offsets><xref ref-type="bibr" rid="CR10"><offsets xml_i="78830" xml_f="78832" txt_i="54453" txt_f="54455">10</offsets></xref><offsets xml_i="78839" xml_f="78841" txt_i="54455" txt_f="54457">, </offsets><xref ref-type="bibr" rid="CR13"><offsets xml_i="78874" xml_f="78876" txt_i="54457" txt_f="54459">13</offsets></xref><offsets xml_i="78883" xml_f="78885" txt_i="54459" txt_f="54461">, </offsets><xref ref-type="bibr" rid="CR14"><offsets xml_i="78918" xml_f="78920" txt_i="54461" txt_f="54463">14</offsets></xref><offsets xml_i="78927" xml_f="78929" txt_i="54463" txt_f="54465">].</offsets></p><p id="Par101"><offsets xml_i="78948" xml_f="78981" txt_i="54466" txt_f="54499">In summary, the objective of the </offsets><italic><offsets xml_i="78989" xml_f="79002" txt_i="54499" txt_f="54512">QUADX-1 trial</offsets></italic><offsets xml_i="79011" xml_f="79606" txt_i="54512" txt_f="55107"> is to investigate the efficacy of three different exercise dosages of pre-operative, home-based, knee-extensor strength exercise before and shortly after surgery in patients eligible for total knee replacement. The results will indicate which knee-extensor strength exercise dosage is most effective for increasing knee-extensor strength in the end-stage knee OA population. Furthermore, the results will indicate whether pre-operative knee-extensor strength exercise improves knee-extensor strength and function prior to surgery and whether this effect (if any) is sustained following surgery.</offsets></p><sec id="Sec39"><title><offsets xml_i="79633" xml_f="79642" txt_i="55108" txt_f="55117">Strengths</offsets></title><p id="Par102"><offsets xml_i="79665" xml_f="80057" txt_i="55118" txt_f="55510">The trial design has several strengths as it addresses numerous gaps in the academic literature. Trials investigating the dose-response relationship of strength exercise in patients with end-stage knee OA are rare. Accordingly, there is a need for investigating the most effective exercise dose in this patient population, as highlighted in two recent systematic reviews using meta-analysis [</offsets><xref ref-type="bibr" rid="CR21"><offsets xml_i="80090" xml_f="80092" txt_i="55510" txt_f="55512">21</offsets></xref><offsets xml_i="80099" xml_f="80101" txt_i="55512" txt_f="55514">, </offsets><xref ref-type="bibr" rid="CR22"><offsets xml_i="80134" xml_f="80136" txt_i="55514" txt_f="55516">22</offsets></xref><offsets xml_i="80143" xml_f="80307" txt_i="55516" txt_f="55680">]. Peer et al. highlight the scarcity of evidence related to exercise dose-response in patients with knee OA needed to guide pre-habilitation in clinical practice [</offsets><xref ref-type="bibr" rid="CR22"><offsets xml_i="80340" xml_f="80342" txt_i="55680" txt_f="55682">22</offsets></xref><offsets xml_i="80349" xml_f="80508" txt_i="55682" txt_f="55841">]. Further, Bartholdy et al. suggest that a 30–40% gain in knee-extensor strength is needed to positively affect pain and disability in patients with knee OA [</offsets><xref ref-type="bibr" rid="CR21"><offsets xml_i="80541" xml_f="80543" txt_i="55841" txt_f="55843">21</offsets></xref><offsets xml_i="80550" xml_f="80685" txt_i="55843" txt_f="55978">], highlighting the need for evidence to suggest the exercise dosage required to obtain adequate improvement in knee-extensor strength.</offsets></p><p id="Par103"><offsets xml_i="80704" xml_f="80795" txt_i="55979" txt_f="56070">Adherence to home-based exercise is reported to be low with a high risk of over-reporting [</offsets><xref ref-type="bibr" rid="CR45"><offsets xml_i="80828" xml_f="80830" txt_i="56070" txt_f="56072">45</offsets></xref><offsets xml_i="80837" xml_f="80838" txt_i="56072" txt_f="56073">–</offsets><xref ref-type="bibr" rid="CR48"><offsets xml_i="80871" xml_f="80873" txt_i="56073" txt_f="56075">48</offsets></xref><offsets xml_i="80880" xml_f="81160" txt_i="56075" txt_f="56355">]. The use of sensors attached to the elastic exercise band will address this in an objective manner. Further, in a recent systematic review on adherence with physiotherapy exercises it was requested that the relationship between adherence and treatment outcome was investigated [</offsets><xref ref-type="bibr" rid="CR46"><offsets xml_i="81193" xml_f="81195" txt_i="56355" txt_f="56357">46</offsets></xref><offsets xml_i="81202" xml_f="81204" txt_i="56357" txt_f="56359">].</offsets></p><p id="Par104"><offsets xml_i="81223" xml_f="81646" txt_i="56360" txt_f="56783">The exercise regimes currently offered to patients with knee OA are mostly supervised exercise sessions at outpatient clinics and comprise several exercises resulting in accumulated time spent and cost. In this trial, a single, simple, home-based exercise is applied, thus, investigating whether an alternative exercise treatment, which is simplified and maintained unsupervised at home, might be offered to these patients.</offsets></p><p id="Par105"><offsets xml_i="81665" xml_f="81789" txt_i="56784" txt_f="56908">This trial protocol follows the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) Checklist (Fig. </offsets><xref rid="Fig2" ref-type="fig"><offsets xml_i="81821" xml_f="81822" txt_i="56908" txt_f="56909">2</offsets></xref><offsets xml_i="81829" xml_f="81847" txt_i="56909" txt_f="56927">, Additional file </offsets><xref rid="MOESM1" ref-type="media"><offsets xml_i="81883" xml_f="81884" txt_i="56927" txt_f="56928">1</offsets></xref><offsets xml_i="81891" xml_f="81894" txt_i="56928" txt_f="56931">) [</offsets><xref ref-type="bibr" rid="CR24"><offsets xml_i="81927" xml_f="81929" txt_i="56931" txt_f="56933">24</offsets></xref><offsets xml_i="81936" xml_f="82031" txt_i="56933" txt_f="57028">] and the exercise intervention is reported according to the TIDieR Checklist (Additional file </offsets><xref rid="MOESM2" ref-type="media"><offsets xml_i="82067" xml_f="82068" txt_i="57028" txt_f="57029">2</offsets></xref><offsets xml_i="82075" xml_f="82078" txt_i="57029" txt_f="57032">) [</offsets><xref ref-type="bibr" rid="CR26"><offsets xml_i="82111" xml_f="82113" txt_i="57032" txt_f="57034">26</offsets></xref><offsets xml_i="82120" xml_f="82217" txt_i="57034" txt_f="57131">] allowing for replication and direct clinical use, which has been requested in a recent review [</offsets><xref ref-type="bibr" rid="CR53"><offsets xml_i="82250" xml_f="82252" txt_i="57131" txt_f="57133">53</offsets></xref><offsets xml_i="82259" xml_f="82420" txt_i="57133" txt_f="57294">]. The cross-sectional design mimics everyday practice of cross-sector boarder communication increasing the external validity for future clinical implementation.</offsets></p></sec><sec id="Sec40"><title><offsets xml_i="82453" xml_f="82464" txt_i="57296" txt_f="57307">Limitations</offsets></title><p id="Par106"><offsets xml_i="82487" xml_f="82678" txt_i="57308" txt_f="57499">The trial has some limitations which must be taken into consideration. There is no control group limiting the inferences that can be made on the effect of the knee-extensor strength exercise.</offsets></p><p id="Par107"><offsets xml_i="82697" xml_f="82945" txt_i="57500" txt_f="57748">Due to the nature of the intervention (exercise) there is a risk of selection bias, e.g., patients motivated for exercise are more likely to participate in the trial. This also limits the external validity with respect the whole knee OA population.</offsets></p><p id="Par108"><offsets xml_i="82964" xml_f="83028" txt_i="57749" txt_f="57813">In the present trial design, the patients are asked about their </offsets><italic><offsets xml_i="83036" xml_f="83052" txt_i="57813" txt_f="57829">need for surgery</offsets></italic><offsets xml_i="83061" xml_f="83277" txt_i="57829" txt_f="58045"> after the 12-week exercise period. In line with the above limitation, the answer to this question could be biased as patients motivated for exercise might be less motivated towards surgery affecting their answer to </offsets><italic><offsets xml_i="83285" xml_f="83301" txt_i="58045" txt_f="58061">need for surgery</offsets></italic><offsets xml_i="83310" xml_f="83319" txt_i="58061" txt_f="58070"> towards.</offsets></p><p id="Par109"><offsets xml_i="83338" xml_f="83519" txt_i="58071" txt_f="58252">Though the sensor objectively measures activity with the elastic exercise band, the sensor cannot measure who is exercising, which muscle is exercised or what movement is performed.</offsets></p><p id="Par110"><offsets xml_i="83538" xml_f="83649" txt_i="58253" txt_f="58364">Finally, no recording or monitoring of the use of knee-related pain medication during the trial is planned for.</offsets></p></sec></sec><sec id="Sec41"><title><offsets xml_i="83688" xml_f="83700" txt_i="58367" txt_f="58379">Trial status</offsets></title><p id="Par111"><offsets xml_i="83723" xml_f="83863" txt_i="58380" txt_f="58520">Protocol version no. 4.1 (21 November 2017). Inclusion began 1 November 2016. Approximate date for inclusion completion is 31 December 2019.</offsets></p></sec><sec sec-type="supplementary-material"><title><offsets xml_i="83919" xml_f="83935" txt_i="58522" txt_f="58538">Additional files</offsets></title><sec id="Sec42"><p><offsets xml_i="83962" xml_f="83963" txt_i="58539" txt_f="58540">
</offsets><supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="13063_2017_2366_MOESM1_ESM.doc"><label><offsets xml_i="84083" xml_f="84101" txt_i="58540" txt_f="58558">Additional file 1:</offsets></label><caption><p><offsets xml_i="84121" xml_f="84151" txt_i="58558" txt_f="58588">SPIRIT Checklist. (DOC 122 kb)</offsets></p></caption></media></supplementary-material><offsets xml_i="84198" xml_f="84199" txt_i="58589" txt_f="58590">
</offsets><supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="13063_2017_2366_MOESM2_ESM.docx"><label><offsets xml_i="84320" xml_f="84338" txt_i="58590" txt_f="58608">Additional file 2:</offsets></label><caption><p><offsets xml_i="84358" xml_f="84388" txt_i="58608" txt_f="58638">TIDieR Checklist. (DOCX 31 kb)</offsets></p></caption></media></supplementary-material><offsets xml_i="84435" xml_f="84436" txt_i="58639" txt_f="58640">
</offsets><supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="13063_2017_2366_MOESM3_ESM.pdf"><label><offsets xml_i="84556" xml_f="84574" txt_i="58640" txt_f="58658">Additional file 3:</offsets></label><caption><p><offsets xml_i="84594" xml_f="84634" txt_i="58658" txt_f="58698">Patient brochure (English). (PDF 825 kb)</offsets></p></caption></media></supplementary-material><offsets xml_i="84681" xml_f="84682" txt_i="58699" txt_f="58700">
</offsets><supplementary-material content-type="local-data" id="MOESM4"><media xlink:href="13063_2017_2366_MOESM4_ESM.docx"><label><offsets xml_i="84803" xml_f="84821" txt_i="58700" txt_f="58718">Additional file 4:</offsets></label><caption><p><offsets xml_i="84841" xml_f="84881" txt_i="58718" txt_f="58758">Administrative information. (DOCX 38 kb)</offsets></p></caption></media></supplementary-material><offsets xml_i="84928" xml_f="84929" txt_i="58759" txt_f="58760">
</offsets></p></sec></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>6MWT</term><def><p id="Par5">6-Minute Walking Test</p></def></def-item><def-item><term>ASA</term><def><p id="Par6">American Society of Anesthesiologists’ physical status classification</p></def></def-item><def-item><term>ICC</term><def><p id="Par7">Intraclass correlation coefficient</p></def></def-item><def-item><term>ITT</term><def><p id="Par8">Intention-to-treat</p></def></def-item><def-item><term>KOOS</term><def><p id="Par9">Knee Osteoarthritis Outcome Score</p></def></def-item><def-item><term>MDC</term><def><p id="Par10">Minimal detectable change</p></def></def-item><def-item><term>Nm/kg</term><def><p id="Par11">Newton-meter (torque) per kilogram body mass</p></def></def-item><def-item><term>NRS</term><def><p id="Par12">Numeric Rating Scale</p></def></def-item><def-item><term>OA</term><def><p id="Par13">Osteoarthritis</p></def></def-item><def-item><term>OKS</term><def><p id="Par14">Oxford Knee Score</p></def></def-item><def-item><term>RM</term><def><p id="Par15">Repetitions-maximum</p></def></def-item><def-item><term>SCT</term><def><p id="Par16">Stair Climb Test</p></def></def-item><def-item><term>SEM</term><def><p id="Par17">Standard error of measurement</p></def></def-item><def-item><term>TKA</term><def><p id="Par18">Total knee arthroplasty</p></def></def-item><def-item><term>TUT</term><def><p id="Par19">Time-under-tension</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Electronic supplementary material</bold></p><p>The online version of this article (10.1186/s13063-017-2366-9) contains supplementary material, which is available to authorized users.</p></fn></fn-group><ack><title>Acknowledgements</title><p>We thank the Steering Committee Team, the Working Group and the employees from the collaborating municipalities for relevant feedback during the design phase.</p><sec id="FPar10"><title>Funding</title><p id="Par112">The Capital Region’s strategic funds (1,500,000 dkkr (financial)) and the Capital Region’s fund for cross-continuum research (500,000 dkkr (financial)). Funding sources of the current trial have had no part in the design, conduction or reporting of the trial, thus there is no conflict of interests.</p></sec><sec id="FPar11"><title>Availability of data and materials</title><p id="Par113">The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request. A fully patient-anonymized dataset and corresponding statistical analysis code will be made available for the scientific journal reviewing the manuscript and its results within 6 months. Contact: Rasmus Skov Husted (rasmus.skov.husted@regionh.dk) and Thomas Bandholm (thomas.quaade.bandholm@regionh.dk) (Additional file <xref rid="MOESM4" ref-type="media">4</xref>).</p></sec></ack><notes notes-type="author-contribution"><title>Authors’ contributions</title><p>TB drafted the original idea for the trial and initiated the trial design. AT, KT, MSR, HH and RSH later contributed to the trial design process. TB and RSH drafted the trial protocol and all other authors contributed and approved the final version of the protocol. TB is the main grant holder and responsible for the completion of the trial. RSH is the trial manager and principal investigator responsible for daily operation, coordination between trial collaborators, outcome assessment of patients, collection and structuring of data, ensuring compliance with milestones and completion of the trial. RSH will draft the manuscripts for publication with contribution and approval of the final version from all co-authors. All authors read and approved the final manuscript.</p></notes><notes notes-type="COI-statement"><sec id="FPar12"><title>Ethics approval and consent to participate</title><p id="Par114">Ethical approval has been granted by the Ethical Committee of the Capital Region Denmark. ID: H-16025136. Confirmation received 13 September 2016. Informed consent will be obtained from all participants of the trial.</p></sec><sec id="FPar13"><title>Consent for publication</title><p id="Par115">Not applicable</p></sec><sec id="FPar14"><title>Competing interests</title><p id="Par116">The authors declare that they have no competing interests.</p></sec><sec id="FPar15"><title>Publisher’s Note</title><p id="Par117">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roos</surname><given-names>EM</given-names></name><name><surname>Toksvig-Larsen</surname><given-names>S</given-names></name></person-group><article-title>Knee injury and Osteoarthritis Outcome Score (KOOS)—validation and comparison to the WOMAC in total knee replacement</article-title><source>Health Qual Life Outcomes</source><year>2003</year><volume>1</volume><fpage>17</fpage><pub-id pub-id-type="doi">10.1186/1477-7525-1-17</pub-id><pub-id pub-id-type="pmid">12801417</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="other">Pedersen A, Mehnert, Odgaard A, Schrøder HM. Existing data sources for clinical epidemiology: The Danish Knee Arthroplasty Register. Clin Epidemiol. 2012;125:125-135.</mixed-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="other">Sundhedsstyrelsen—Knæartrose. Nationale kliniske retningslinjer og faglige visitationsretningslinjer. KBH. 2012;1:1-80.</mixed-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Svege</surname><given-names>I</given-names></name><name><surname>Nordsletten</surname><given-names>L</given-names></name><name><surname>Fernandes</surname><given-names>L</given-names></name><name><surname>Risberg</surname><given-names>MA</given-names></name></person-group><article-title>Exercise therapy may postpone total hip replacement surgery in patients with hip osteoarthritis: a long-term follow-up of a randomised trial</article-title><source>Ann Rheum Dis</source><year>2015</year><volume>74</volume><fpage>164</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1136/annrheumdis-2013-203628</pub-id><pub-id pub-id-type="pmid">24255546</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Lee</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Moodie</surname><given-names>J</given-names></name><name><surname>Cheng</surname><given-names>D</given-names></name><name><surname>Martin</surname><given-names>J</given-names></name></person-group><article-title>Does preoperative rehabilitation for patients planning to undergo joint replacement surgery improve outcomes? A systematic review and meta-analysis of randomised controlled trials</article-title><source>BMJ Open</source><year>2016</year><volume>6</volume><fpage>e009857</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2015-009857</pub-id><pub-id pub-id-type="pmid">26839013</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skou</surname><given-names>ST</given-names></name><name><surname>Roos</surname><given-names>EM</given-names></name><name><surname>Laursen</surname><given-names>MB</given-names></name><name><surname>Rathleff</surname><given-names>MS</given-names></name><name><surname>Arendt-Nielsen</surname><given-names>L</given-names></name><name><surname>Simonsen</surname><given-names>O</given-names></name><etal></etal></person-group><article-title>A randomized, controlled trial of total knee replacement</article-title><source>N Engl J Med</source><year>2015</year><volume>373</volume><fpage>1597</fpage><lpage>606</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1505467</pub-id><pub-id pub-id-type="pmid">26488691</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bade</surname><given-names>MJ</given-names></name><name><surname>Kohrt</surname><given-names>WM</given-names></name><name><surname>Stevens-Lapsley</surname><given-names>JE</given-names></name></person-group><article-title>Outcomes before and after total knee arthroplasty compared to healthy adults</article-title><source>J Orthop Sports Phys Ther</source><year>2010</year><volume>40</volume><fpage>559</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.2519/jospt.2010.3317</pub-id><pub-id pub-id-type="pmid">20710093</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Esch</surname><given-names>M</given-names></name><name><surname>Holla</surname><given-names>JF</given-names></name><name><surname>van der Leeden</surname><given-names>M</given-names></name><name><surname>Knol</surname><given-names>DL</given-names></name><name><surname>Lems</surname><given-names>WF</given-names></name><name><surname>Roorda</surname><given-names>LD</given-names></name><etal></etal></person-group><article-title>Decrease of muscle strength is associated with increase of activity limitations in early knee osteoarthritis: 3-year results from the cohort hip and cohort knee study</article-title><source>Arch Phys Med Rehabil</source><year>2014</year><volume>95</volume><fpage>1962</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.apmr.2014.06.007</pub-id><pub-id pub-id-type="pmid">24977932</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Culvenor</surname><given-names>AG</given-names></name><name><surname>Ruhdorfer</surname><given-names>A</given-names></name><name><surname>Juhl</surname><given-names>C</given-names></name><name><surname>Eckstein</surname><given-names>F</given-names></name><name><surname>Øiestad</surname><given-names>BE</given-names></name></person-group><article-title></article-title><source>Arthritis Care Res</source><year>2017</year><volume>69</volume><fpage>649</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1002/acr.23005</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Øiestad</surname><given-names>BE</given-names></name><name><surname>Juhl</surname><given-names>CB</given-names></name><name><surname>Eitzen</surname><given-names>I</given-names></name><name><surname>Thorlund</surname><given-names>JB</given-names></name></person-group><article-title>Knee extensor muscle weakness is a risk factor for development of knee osteoarthritis. A systematic review and meta-analysis</article-title><source>Osteoarthr Cartil</source><year>2015</year><volume>23</volume><fpage>171</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.joca.2014.10.008</pub-id><pub-id pub-id-type="pmid">25450853</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holm</surname><given-names>B</given-names></name><name><surname>Kristensen</surname><given-names>MT</given-names></name><name><surname>Bencke</surname><given-names>J</given-names></name><name><surname>Husted</surname><given-names>H</given-names></name><name><surname>Kehlet</surname><given-names>H</given-names></name><name><surname>Bandholm</surname><given-names>T</given-names></name></person-group><article-title>Loss of knee-extension strength is related to knee swelling after total knee arthroplasty</article-title><source>Arch Phys Med Rehabil</source><year>2010</year><volume>91</volume><fpage>1770</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.apmr.2010.07.229</pub-id><pub-id pub-id-type="pmid">21044725</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Husted</surname><given-names>H</given-names></name><name><surname>Lunn</surname><given-names>TH</given-names></name><name><surname>Troelsen</surname><given-names>A</given-names></name><name><surname>Gaarn-Larsen</surname><given-names>L</given-names></name><name><surname>Kristensen</surname><given-names>BB</given-names></name><name><surname>Kehlet</surname><given-names>H</given-names></name></person-group><article-title>Why still in hospital after fast-track hip and knee arthroplasty?</article-title><source>Acta Orthop</source><year>2011</year><volume>82</volume><fpage>679</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.3109/17453674.2011.636682</pub-id><pub-id pub-id-type="pmid">22066560</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juhl</surname><given-names>C</given-names></name><name><surname>Christensen</surname><given-names>R</given-names></name><name><surname>Roos</surname><given-names>EM</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Lund</surname><given-names>H</given-names></name></person-group><article-title>Impact of exercise type and dose on pain and disability in knee osteoarthritis: a systematic review and meta-regression analysis of randomized controlled trials: impact of exercise type and dose in knee osteoarthritis</article-title><source>Arthritis Rheum</source><year>2014</year><volume>66</volume><fpage>622</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1002/art.38290</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McAlindon</surname><given-names>TE</given-names></name><name><surname>Bannuru</surname><given-names>RR</given-names></name><name><surname>Sullivan</surname><given-names>MC</given-names></name><name><surname>Arden</surname><given-names>NK</given-names></name><name><surname>Berenbaum</surname><given-names>F</given-names></name><name><surname>Bierma-Zeinstra</surname><given-names>SM</given-names></name><etal></etal></person-group><article-title>OARSI guidelines for the non-surgical management of knee osteoarthritis</article-title><source>Osteoarthr Cartil OARS Osteoarthr Res Soc</source><year>2014</year><volume>22</volume><fpage>363</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1016/j.joca.2014.01.003</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calatayud</surname><given-names>J</given-names></name><name><surname>Casaña</surname><given-names>J</given-names></name><name><surname>Ezzatvar</surname><given-names>Y</given-names></name><name><surname>Jakobsen</surname><given-names>MD</given-names></name><name><surname>Sundstrup</surname><given-names>E</given-names></name><name><surname>Andersen</surname><given-names>LL</given-names></name></person-group><article-title>High-intensity preoperative training improves physical and functional recovery in the early post-operative periods after total knee arthroplasty: a randomized controlled trial</article-title><source>Knee Surg Sports Traumatol Arthrosc</source><year>2016</year><pub-id pub-id-type="pmid">26768606</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="other">Skoffer B, Maribo T, Mechlenburg I, Hansen PM, Søballe K, Dalgas U. Efficacy of pre-operative progressive resistance training on post-operative outcomes in patients undergoing total knee arthroplasty: progressive resistance training before total knee arthroplasty. Arthritis Care Res. 2015;29:14-29.</mixed-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ratamess</surname><given-names>NA</given-names></name><name><surname>Alvar</surname><given-names>BA</given-names></name><name><surname>Evetoch</surname><given-names>TK</given-names></name><name><surname>Housh</surname><given-names>TJ</given-names></name><name><surname>Kibler</surname><given-names>WB</given-names></name><name><surname>Kraemer</surname><given-names>WJ</given-names></name><etal></etal></person-group><article-title>Progression models in resistance training for healthy adults</article-title><source>Med Sci Sports Exerc</source><year>2009</year><volume>41</volume><fpage>687</fpage><lpage>708</lpage><pub-id pub-id-type="doi">10.1249/MSS.0b013e3181915670</pub-id><pub-id pub-id-type="pmid">19204579</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borde</surname><given-names>R</given-names></name><name><surname>Hortobágyi</surname><given-names>T</given-names></name><name><surname>Granacher</surname><given-names>U</given-names></name></person-group><article-title>Dose-response relationships of resistance training in healthy old adults: a systematic review and meta-analysis</article-title><source>Sports Med</source><year>2015</year><volume>45</volume><fpage>1693</fpage><lpage>720</lpage><pub-id pub-id-type="doi">10.1007/s40279-015-0385-9</pub-id><pub-id pub-id-type="pmid">26420238</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhea</surname><given-names>MR</given-names></name><name><surname>Alvar</surname><given-names>BA</given-names></name><name><surname>Burkett</surname><given-names>LN</given-names></name><name><surname>Ball</surname><given-names>SD</given-names></name></person-group><article-title>A meta-analysis to determine the dose response for strength development</article-title><source>Med Sci Sports Exerc</source><year>2003</year><volume>35</volume><fpage>456</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1249/01.MSS.0000053727.63505.D4</pub-id><pub-id pub-id-type="pmid">12618576</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farrugia</surname><given-names>P</given-names></name><name><surname>Petrisor</surname><given-names>BA</given-names></name><name><surname>Farrokhyar</surname><given-names>F</given-names></name><name><surname>Bhandari</surname><given-names>M</given-names></name></person-group><article-title>Practical tips for surgical research: Research questions, hypotheses and objectives</article-title><source>Can J Surg J Can Chir</source><year>2010</year><volume>53</volume><fpage>278</fpage><lpage>81</lpage></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartholdy</surname><given-names>C</given-names></name><name><surname>Juhl</surname><given-names>C</given-names></name><name><surname>Christensen</surname><given-names>R</given-names></name><name><surname>Lund</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Henriksen</surname><given-names>M</given-names></name></person-group><article-title>The role of muscle strengthening in exercise therapy for knee osteoarthritis: a systematic review and meta-regression analysis of randomized trials</article-title><source>Semin Arthritis Rheum</source><year>2017</year><pub-id pub-id-type="pmid">28438380</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peer</surname><given-names>M</given-names></name><name><surname>Rush</surname><given-names>R</given-names></name><name><surname>Gallacher</surname><given-names>P</given-names></name><name><surname>Gleeson</surname><given-names>N</given-names></name></person-group><article-title>Pre-surgery exercise and post-operative physical function of people undergoing knee replacement surgery: a systematic review and meta-analysis of randomized controlled trials</article-title><source>J Rehabil Med</source><year>2017</year><volume>49</volume><fpage>304</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.2340/16501977-2210</pub-id><pub-id pub-id-type="pmid">28352936</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bandholm</surname><given-names>T</given-names></name><name><surname>Christensen</surname><given-names>R</given-names></name><name><surname>Thorborg</surname><given-names>K</given-names></name><name><surname>Treweek</surname><given-names>S</given-names></name><name><surname>Henriksen</surname><given-names>M</given-names></name></person-group><article-title>Preparing for what the reporting checklists will not tell you: the PREPARE Trial guide for planning clinical research to avoid research waste</article-title><source>Br J Sports Med</source><year>2017</year><volume>51</volume><issue>20</issue><fpage>1494</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1136/bjsports-2017-097527</pub-id><pub-id pub-id-type="pmid">28882839</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><mixed-citation publication-type="other">Chan A-W, Tetzlaff J, Gøtzsche P, Altman DG, Dickersin K, Hróbjartsson A, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;8:346-388.</mixed-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moher</surname><given-names>D</given-names></name><name><surname>Hopewell</surname><given-names>S</given-names></name><name><surname>Schulz</surname><given-names>KF</given-names></name><name><surname>Montori</surname><given-names>V</given-names></name><name><surname>Gøtzsche</surname><given-names>PC</given-names></name><name><surname>Devereaux</surname><given-names>PJ</given-names></name><etal></etal></person-group><article-title>CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials</article-title><source>Int J Surg</source><year>2012</year><volume>10</volume><fpage>28</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1016/j.ijsu.2011.10.001</pub-id><pub-id pub-id-type="pmid">22036893</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffmann</surname><given-names>TC</given-names></name><name><surname>Glasziou</surname><given-names>PP</given-names></name><name><surname>Boutron</surname><given-names>I</given-names></name><name><surname>Milne</surname><given-names>R</given-names></name><name><surname>Perera</surname><given-names>R</given-names></name><name><surname>Moher</surname><given-names>D</given-names></name><etal></etal></person-group><article-title>Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide</article-title><source>BMJ</source><year>2014</year><volume>348</volume><fpage>g1687</fpage><pub-id pub-id-type="doi">10.1136/bmj.g1687</pub-id><pub-id pub-id-type="pmid">24609605</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skoffer</surname><given-names>B</given-names></name><name><surname>Maribo</surname><given-names>T</given-names></name><name><surname>Mechlenburg</surname><given-names>I</given-names></name><name><surname>Hansen</surname><given-names>PM</given-names></name><name><surname>Søballe</surname><given-names>K</given-names></name><name><surname>Dalgas</surname><given-names>U</given-names></name></person-group><article-title>Efficacy of preoperative progressive resistance training on postoperative outcomes in patients undergoing total knee arthroplasty: progressive resistance training before TKA</article-title><source>Arthritis Care Res</source><year>2016</year></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villadsen</surname><given-names>A</given-names></name><name><surname>Overgaard</surname><given-names>S</given-names></name><name><surname>Holsgaard-Larsen</surname><given-names>A</given-names></name><name><surname>Christensen</surname><given-names>R</given-names></name><name><surname>Roos</surname><given-names>EM</given-names></name></person-group><article-title>Postoperative effects of neuromuscular exercise prior to hip or knee arthroplasty: a randomised controlled trial</article-title><source>Ann Rheum Dis</source><year>2014</year><volume>73</volume><fpage>1130</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1136/annrheumdis-2012-203135</pub-id><pub-id pub-id-type="pmid">23661494</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>American Society of Anesthesiologists</collab></person-group><source>ASA Physical Status Classification System</source><year>2014</year></element-citation></ref><ref id="CR30"><label>30.</label><mixed-citation publication-type="other">The QUADX-1 Trial. Home-based knee-extensor exercise. <ext-link ext-link-type="uri" xlink:href="https://www.youtube.com/watch?v=bAXzuWBTjrw">https://www.youtube.com/watch?v=bAXzuWBTjrw</ext-link>. Accessed 17 Sept 2017.</mixed-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toigo</surname><given-names>M</given-names></name><name><surname>Boutellier</surname><given-names>U</given-names></name></person-group><article-title>New fundamental resistance exercise determinants of molecular and cellular muscle adaptations</article-title><source>Eur J Appl Physiol</source><year>2006</year><volume>97</volume><fpage>643</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1007/s00421-006-0238-1</pub-id><pub-id pub-id-type="pmid">16845551</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>BE</given-names></name><name><surname>Hendrick</surname><given-names>P</given-names></name><name><surname>Smith</surname><given-names>TO</given-names></name><name><surname>Bateman</surname><given-names>M</given-names></name><name><surname>Moffatt</surname><given-names>F</given-names></name><name><surname>Rathleff</surname><given-names>MS</given-names></name><etal></etal></person-group><article-title>Should exercises be painful in the management of chronic musculoskeletal pain? A systematic review and meta-analysis</article-title><source>Br J Sports Med</source><year>2017</year><volume>51</volume><issue>23</issue><fpage>1679</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1136/bjsports-2016-097383</pub-id><pub-id pub-id-type="pmid">28596288</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><mixed-citation publication-type="other">Dobson F, Bennell KL, Hinman RS, Abbott JH, Roos EM. Recommended performance-based tests to assess physical function in people diagnosed with hip or knee osteoarthritis. Melbourne: OARSI; 2012.</mixed-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Losina</surname><given-names>E</given-names></name><name><surname>Ranstam</surname><given-names>J</given-names></name><name><surname>Collins</surname><given-names>JE</given-names></name><name><surname>Schnitzer</surname><given-names>TJ</given-names></name><name><surname>Katz</surname><given-names>JN</given-names></name></person-group><article-title>OARSI Clinical Trials Recommendations: key analytic considerations in design, analysis, and reporting of randomized controlled trials in osteoarthritis</article-title><source>Osteoarthr Cartil</source><year>2015</year><volume>23</volume><fpage>677</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1016/j.joca.2015.03.011</pub-id><pub-id pub-id-type="pmid">25952341</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gagnon</surname><given-names>D</given-names></name><name><surname>Nadeau</surname><given-names>S</given-names></name><name><surname>Gravel</surname><given-names>D</given-names></name><name><surname>Robert</surname><given-names>J</given-names></name><name><surname>Bélanger</surname><given-names>D</given-names></name><name><surname>Hilsenrath</surname><given-names>M</given-names></name></person-group><article-title>Reliability and validity of static knee strength measurements obtained with a chair-fixed dynamometer in subjects with hip or knee arthroplasty</article-title><source>Arch Phys Med Rehabil</source><year>2005</year><volume>86</volume><fpage>1998</fpage><lpage>2008</lpage><pub-id pub-id-type="doi">10.1016/j.apmr.2005.04.013</pub-id><pub-id pub-id-type="pmid">16213245</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jakobsen</surname><given-names>TL</given-names></name><name><surname>Kehlet</surname><given-names>H</given-names></name><name><surname>Bandholm</surname><given-names>T</given-names></name></person-group><article-title>Reliability of the 6-min walk test after total knee arthroplasty</article-title><source>Knee Surg Sports Traumatol Arthrosc</source><year>2013</year><volume>21</volume><fpage>2625</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1007/s00167-012-2054-y</pub-id><pub-id pub-id-type="pmid">22644072</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parent</surname><given-names>E</given-names></name><name><surname>Moffet</surname><given-names>H</given-names></name></person-group><article-title>Comparative responsiveness of locomotor tests and questionnaires used to follow early recovery after total knee arthroplasty</article-title><source>Arch Phys Med Rehabil</source><year>2002</year><volume>83</volume><fpage>70</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1053/apmr.2002.27337</pub-id><pub-id pub-id-type="pmid">11782835</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almeida</surname><given-names>GJ</given-names></name><name><surname>Schroeder</surname><given-names>CA</given-names></name><name><surname>Gil</surname><given-names>AB</given-names></name><name><surname>Fitzgerald</surname><given-names>GK</given-names></name><name><surname>Piva</surname><given-names>SR</given-names></name></person-group><article-title>Interrater reliability and validity of the stair ascend/descend test in subjects with total knee arthroplasty</article-title><source>Arch Phys Med Rehabil</source><year>2010</year><volume>91</volume><fpage>932</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.apmr.2010.02.003</pub-id><pub-id pub-id-type="pmid">20510986</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>NJ</given-names></name><name><surname>Misra</surname><given-names>D</given-names></name><name><surname>Felson</surname><given-names>DT</given-names></name><name><surname>Crossley</surname><given-names>KM</given-names></name><name><surname>Roos</surname><given-names>EM</given-names></name></person-group><article-title>Measures of knee function: International Knee Documentation Committee (IKDC) Subjective Knee Evaluation Form, Knee Injury and Osteoarthritis Outcome Score (KOOS), Knee Injury and Osteoarthritis Outcome Score Physical Function Short Form (KOOS-PS), Knee Outcome Survey Activities of Daily Living Scale (KOS-ADL), Lysholm Knee Scoring Scale, Oxford Knee Score (OKS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Activity Rating Scale (ARS), and Tegner Activity Score (TAS)</article-title><source>Arthritis Care Res</source><year>2011</year><volume>63</volume><fpage>S208</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1002/acr.20632</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>NJ</given-names></name><name><surname>Roos</surname><given-names>EM</given-names></name></person-group><article-title>Patient-reported outcomes for total hip and knee arthroplasty</article-title><source>Clin Geriatr Med</source><year>2012</year><volume>28</volume><fpage>367</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1016/j.cger.2012.05.007</pub-id><pub-id pub-id-type="pmid">22840304</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>KK</given-names></name><name><surname>Dawson</surname><given-names>J</given-names></name><name><surname>Jones</surname><given-names>LD</given-names></name><name><surname>Beard</surname><given-names>DJ</given-names></name><name><surname>Price</surname><given-names>AJ</given-names></name></person-group><article-title>Extending the use of PROMs in the NHS—using the Oxford Knee Score in patients undergoing non-operative management for knee osteoarthritis: a validation study</article-title><source>BMJ Open</source><year>2013</year><volume>3</volume><fpage>e003365</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2013-003365</pub-id><pub-id pub-id-type="pmid">23965934</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gagliese</surname><given-names>L</given-names></name><name><surname>Weizblit</surname><given-names>N</given-names></name><name><surname>Ellis</surname><given-names>W</given-names></name><name><surname>Chan</surname><given-names>VWS</given-names></name></person-group><article-title>The measurement of postoperative pain: a comparison of intensity scales in younger and older surgical patients</article-title><source>Pain</source><year>2005</year><volume>117</volume><fpage>412</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.pain.2005.07.004</pub-id><pub-id pub-id-type="pmid">16153776</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Herr</surname><given-names>K</given-names></name></person-group><article-title>Postoperative pain intensity assessment: a comparison of four scales in Chinese adults</article-title><source>Pain Med</source><year>2007</year><volume>8</volume><fpage>223</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1111/j.1526-4637.2007.00296.x</pub-id><pub-id pub-id-type="pmid">17371409</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sloman</surname><given-names>R</given-names></name><name><surname>Wruble</surname><given-names>AW</given-names></name><name><surname>Rosen</surname><given-names>G</given-names></name><name><surname>Rom</surname><given-names>M</given-names></name></person-group><article-title>Determination of clinically meaningful levels of pain reduction in patients experiencing acute postoperative pain</article-title><source>Pain Manag Nurs</source><year>2006</year><volume>7</volume><fpage>153</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.pmn.2006.09.001</pub-id><pub-id pub-id-type="pmid">17145489</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>R</given-names></name><name><surname>Evans</surname><given-names>M</given-names></name><name><surname>Tucker</surname><given-names>M</given-names></name><name><surname>Quilty</surname><given-names>B</given-names></name><name><surname>Dieppe</surname><given-names>P</given-names></name><name><surname>Donovan</surname><given-names>JL</given-names></name></person-group><article-title>Why don’t patients do their exercises? Understanding non-compliance with physiotherapy in patients with osteoarthritis of the knee</article-title><source>J Epidemiol Community Health</source><year>2001</year><volume>55</volume><fpage>132</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1136/jech.55.2.132</pub-id><pub-id pub-id-type="pmid">11154253</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLean</surname><given-names>SM</given-names></name><name><surname>Burton</surname><given-names>M</given-names></name><name><surname>Bradley</surname><given-names>L</given-names></name><name><surname>Littlewood</surname><given-names>C</given-names></name></person-group><article-title>Interventions for enhancing adherence with physiotherapy: a systematic review</article-title><source>Man Ther</source><year>2010</year><volume>15</volume><fpage>514</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1016/j.math.2010.05.012</pub-id><pub-id pub-id-type="pmid">20630793</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Picorelli</surname><given-names>AMA</given-names></name><name><surname>Pereira</surname><given-names>LSM</given-names></name><name><surname>Pereira</surname><given-names>DS</given-names></name><name><surname>Felício</surname><given-names>D</given-names></name><name><surname>Sherrington</surname><given-names>C</given-names></name></person-group><article-title>Adherence to exercise programs for older people is influenced by program characteristics and personal factors: a systematic review</article-title><source>J Physiother.</source><year>2014</year><volume>60</volume><fpage>151</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.jphys.2014.06.012</pub-id><pub-id pub-id-type="pmid">25092418</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ravaud</surname><given-names>P</given-names></name></person-group><article-title>Management of osteoarthritis (OA) with an unsupervised home based exercise programme and/or patient administered assessment tools. A cluster randomised controlled trial with a 2x2 factorial design</article-title><source>Ann Rheum Dis</source><year>2004</year><volume>63</volume><fpage>703</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1136/ard.2003.009803</pub-id><pub-id pub-id-type="pmid">15140778</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rathleff</surname><given-names>MS</given-names></name><name><surname>Bandholm</surname><given-names>T</given-names></name><name><surname>Ahrendt</surname><given-names>P</given-names></name><name><surname>Olesen</surname><given-names>JL</given-names></name><name><surname>Thorborg</surname><given-names>K</given-names></name></person-group><article-title>Novel stretch-sensor technology allows quantification of adherence and quality of home-exercises: a validation study</article-title><source>Br J Sports Med</source><year>2014</year><volume>48</volume><fpage>724</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1136/bjsports-2012-091859</pub-id><pub-id pub-id-type="pmid">23467964</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rathleff</surname><given-names>MS</given-names></name><name><surname>Thorborg</surname><given-names>K</given-names></name><name><surname>Rode</surname><given-names>LA</given-names></name><name><surname>McGirr</surname><given-names>KA</given-names></name><name><surname>Sørensen</surname><given-names>AS</given-names></name><name><surname>Bøgild</surname><given-names>A</given-names></name><etal></etal></person-group><article-title>Adherence to commonly prescribed, home-based strength training exercises for the lower extremity can be objectively monitored using the Bandcizer</article-title><source>J Strength Cond Res</source><year>2015</year><volume>29</volume><fpage>627</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1519/JSC.0000000000000675</pub-id><pub-id pub-id-type="pmid">25226323</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennell</surname><given-names>KL</given-names></name><name><surname>Kyriakides</surname><given-names>M</given-names></name><name><surname>Metcalf</surname><given-names>B</given-names></name><name><surname>Egerton</surname><given-names>T</given-names></name><name><surname>Wrigley</surname><given-names>TV</given-names></name><name><surname>Hodges</surname><given-names>PW</given-names></name><etal></etal></person-group><article-title>Neuromuscular versus quadriceps strengthening exercise in patients with medial knee osteoarthritis and varus malalignment: a randomized controlled trial: neuromuscular exercise and knee adduction moment</article-title><source>Arthritis Rheumatol</source><year>2014</year><volume>66</volume><fpage>950</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1002/art.38317</pub-id><pub-id pub-id-type="pmid">24757146</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taichman</surname><given-names>DB</given-names></name><name><surname>Backus</surname><given-names>J</given-names></name><name><surname>Baethge</surname><given-names>C</given-names></name><name><surname>Bauchner</surname><given-names>H</given-names></name><name><surname>de Leeuw</surname><given-names>PW</given-names></name><name><surname>Drazen</surname><given-names>JM</given-names></name><etal></etal></person-group><article-title>Editorial-sharing clinical trial data: a proposal from the International Committee of Medical Journal Editors</article-title><source>Ethiop J Health Sci</source><year>2016</year><volume>26</volume><fpage>2</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.4314/ejhs.v26i1.2</pub-id><pub-id pub-id-type="pmid">26949309</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffmann</surname><given-names>TC</given-names></name><name><surname>Maher</surname><given-names>CG</given-names></name><name><surname>Briffa</surname><given-names>T</given-names></name><name><surname>Sherrington</surname><given-names>C</given-names></name><name><surname>Bennell</surname><given-names>K</given-names></name><name><surname>Alison</surname><given-names>J</given-names></name><etal></etal></person-group><article-title>Prescribing exercise interventions for patients with chronic conditions</article-title><source>CMAJ</source><year>2016</year><volume>188</volume><issue>7</issue><fpage>510</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1503/cmaj.150684</pub-id><pub-id pub-id-type="pmid">26976965</pub-id></element-citation></ref></ref-list></back></article>